obsolete_sarcoidosis: ['An idiopathic inflammatory disorder characterized by the formation of non-necrotizing epithelioid granulomas which contain giant cells. It usually affects the lungs, lymph nodes, liver, and skin.', 'An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.']
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
5554 |
4. Check minimum number of eventsNone |
5554 |
5. Include endpointsNone |
5554 |
6. Filter based on genotype QC (FinnGen only) |
5554 |
Control definitions (FinnGen only)
- Control exclude
- D3_IMMUNEMECHANISM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D80-D89
- Name in latin
- Sarcoidosis
Similar endpoints
↥List of similar endpoints to
Sarcoidosis
based on the number of shared cases.
Similar with more cases:
- Certain disorders involving the immune mechanism
- Diagnoses used for exclusion with ILD
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Excluding asthma or asthma-COPD overlap
- COPD differential diagnosis
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 34942 | 18933 | 15788 |
| Only index persons | 30759 | 16617 | 14142 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.49 | 0.54 | 0.44 |
| Only index persons | 0.58 | 0.61 | 0.54 |
| Median age at first event (years) | |||
| Whole population | 46.39 | 49.71 | 42.37 |
| Only index persons | 45.23 | 48.24 | 41.69 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5554 | 3113 | 2441 |
| Unadjusted period prevalence (%) | 1.07 | 1.06 | 1.08 |
| Median age at first event (years) | 46.75 | 48.25 | 44.84 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 5000
- Matched controls
- 49999
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D86.0
ICD-10 Finland
Sarcoidosis of lung
14511.8
323.0
1870
*
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
+∞
323.0
1270
*
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
14239.8
323.0
1122
*
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
+∞
323.0
833
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
7.5
323.0
1015
1647
1350A
ICD-9 Finland
Sarcoidosis[SARCOIDOSIS]
+∞
323.0
426
*
I41.8*D86.8
ICD-10 Finland
Sarcoid myocarditis
3253.8
323.0
316
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.4
323.0
2991
15103
D86.3
ICD-10 Finland
Sarcoidosis of skin
3457.9
323.0
334
*
132
Kela drug reimbursment
Sarcoidosis
+∞
323.0
897
*
13599
ICD-8 Finland
Sarcoidosis, Unspecified
+∞
323.0
457
*
TGC00
NOMESCO Finland
Bronchial lavation
14.7
323.0
574
437
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
+∞
323.0
1047
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
9.7
323.0
828
1000
13597
ICD-8 Finland
Sarcoidosis, Suspecta
+∞
323.0
524
*
H02AB06
ATC
prednisolone; systemic
3.6
323.0
3213
16696
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
8.1
323.0
1378
2231
GEA00
NOMESCO Finland
Mediastinoscopy
72.3
239.0
274
40
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
9.9
228.4
483
535
D86
ICD-10 Finland
Sarcoidosis
768.7
225.9
221
*
XG410
NOMESCO Finland
Flow-volume spirometry
7.0
201.7
535
846
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
28.0
193.2
268
101
I41.8
ICD-10 Finland
Myocarditis in other diseases classified elsewhere
937.2
185.6
181
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.7
151.9
558
1292
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
7.6
151.7
373
522
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.0
140.7
366
555
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
33.1
137.3
182
57
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.7
134.8
648
1918
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
82.0
134.1
151
19
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.3
115.7
459
1136
M14.8*D86.8
ICD-10 Finland
Arthropathy in sarcoidosis
+∞
108.7
104
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.2
103.0
1247
6463
FPG32
NOMESCO Finland
Implantation of cardioverter-defibrillator with atrial and ventricular electrodes
16.7
101.1
165
102
A02BC02
ATC
pantoprazole; systemic
1.9
95.4
3328
25649
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
10.2
94.3
192
194
N16.2*D86.8
ICD-10 Finland
Renal tubulo-interstitial disorders in sarcoidosis
+∞
94.0
90
*
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
9.5
92.8
197
215
R03AC02
ATC
salbutamol; inhalant
1.8
92.5
2695
19416
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
3.6
92.2
455
1357
M05BA04
ATC
alendronic acid; oral
3.1
90.9
554
1935
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.3
90.2
957
4617
L04AX01
ATC
azathioprine; systemic
4.1
89.3
377
983
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
89.2
1715
10635
FM1JR
NOMESCO Finland
Heart, extensive metabolic PET with CT
46.4
88.7
109
24
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
30.9
87.9
118
39
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.3
85.8
463
1479
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
16.7
84.7
138
85
H22.1*D86.8
ICD-10 Finland
Iridocyclitis in sarcoidosis
790.6
79.6
78
*
R06.0
ICD-10 Finland
Dyspnoea
2.0
76.9
1286
7483
I44.2
ICD-10 Finland
Atrioventricular block, complete
5.8
75.2
223
399
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
74.6
969
5078
TGD00
NOMESCO Finland
Needle biopsy of lung
18.1
68.6
108
61
GD1AD
NOMESCO Finland
Thorax CT examination
3.7
68.1
318
901
H20.1
ICD-10 Finland
Chronic iridocyclitis
8.8
65.1
143
166
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
3.5
64.3
318
944
R03BA02
ATC
budesonide; inhalant
2.0
64.0
940
5146
H04.10
ICD-10 Finland
Dry eye syndrome
2.5
63.5
570
2489
R05
ICD-10 Finland
Cough
2.0
62.3
1009
5726
L52
ICD-10 Finland
Erythema nodosum
12.8
62.0
112
89
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.4
61.4
554
2422
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
3.6
61.2
297
868
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
3.8
60.2
271
744
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
59.5
1105
6580
G53.2*D86.8
ICD-10 Finland
Multiple cranial nerve palsies in sarcoidosis
+∞
55.3
53
*
TFJ02
NOMESCO Finland
Muscle biopsy of heart
27.2
54.3
75
28
C03CA01
ATC
furosemide; systemic
1.8
53.8
1258
8038
R50.9
ICD-10 Finland
Fever, unspecified
2.0
52.2
709
3729
C07AB07
ATC
bisoprolol; oral
1.6
49.4
2176
16438
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
8.6
47.7
106
126
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
37.3
46.3
59
16
J45.1
ICD-10 Finland
Nonallergic asthma
2.5
45.8
389
1640
TAB00
NOMESCO Finland
Lumbar puncture
3.0
45.2
283
994
H02AB07
ATC
prednisone; oral
1.9
44.3
733
4141
H30.2
ICD-10 Finland
Posterior cyclitis
22.8
43.5
63
28
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
43.5
844
5033
1440
FHL
Mediastinoscopy
147.9
41.8
44
*
1240
FHL
Bronchoscopy
8.4
41.6
93
112
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.1
41.2
506
2540
WX892
NOMESCO Finland
Monitored bed care
2.3
41.0
410
1874
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
10.0
41.0
83
84
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
12.1
40.7
75
63
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
40.6
1871
14075
H02AB04
ATC
methylprednisolone; systemic
1.8
40.3
729
4237
R03BA08
ATC
ciclesonide; inhalant
2.2
40.2
454
2195
G47.3
ICD-10 Finland
Sleep apnoea
1.7
39.8
1049
6850
AP4
HP
Myocardial biopsy
24.6
39.7
56
23
N16.2
ICD-10 Finland
Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism
+∞
39.6
38
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
38.9
1337
9356
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
37.8
415
1981
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.7
36.6
892
5679
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
36.2
992
6522
R03BA01
ATC
beclometasone; inhalant
1.8
36.1
685
4035
M14.8
ICD-10 Finland
Arthropathies in other specified diseases classified elsewhere
186.3
35.8
37
*
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
3.0
35.4
214
733
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
35.2
455
2326
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
35.2
622
3573
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
4.5
34.6
126
285
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
34.4
1253
8843
I44.1
ICD-10 Finland
Atrioventricular block, second degree
4.4
33.5
125
290
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
33.3
1006
6766
I47.2
ICD-10 Finland
Ventricular tachycardia
3.8
32.8
142
378
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.1
32.1
401
2019
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
5.1
31.6
102
204
J01MA12
ATC
levofloxacin; systemic
1.6
31.2
838
5456
JN4BD
NOMESCO Finland
Extensive body CT
1.9
31.0
527
2983
P01BA02
ATC
hydroxychloroquine; oral
2.0
30.4
407
2107
L04AA06
ATC
mycophenolic acid; systemic
4.0
29.9
122
309
J01FA06
ATC
roxithromycin; oral
1.4
29.7
1840
14443
FM1CG
NOMESCO Finland
Extensive examination of hear with high intensity magnet
10.5
29.6
58
56
N02BE01
ATC
paracetamol; systemic, rectal
1.5
29.5
4065
37061
R03AK08
ATC
formoterol and beclometasone; inhalant
2.7
28.9
208
797
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.4
28.9
260
1127
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
10.3
28.8
57
56
XF404
NOMESCO Finland
Ambulatory ECG
1.9
28.4
443
2429
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
13.4
28.1
49
37
XG474
NOMESCO Finland
Exhalation nntrogen oxide
3.0
28.1
167
566
51925
ICD-8 Finland
Other diseases of respiratory system, Infiltratio pulmonis NUD
15.5
28.1
46
30
E83.50
ICD-10 Finland
Hypercalcemia
5.0
27.8
91
185
WZC30
NOMESCO Finland
Teaching
1.7
27.7
615
3783
UJF32
NOMESCO Finland
Coloscopy
1.5
27.5
1135
8174
R03AK07
ATC
formoterol and budesonide; inhalant
1.6
27.2
868
5884
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.5
27.1
225
936
H02AB09
ATC
hydrocortisone; systemic
3.5
26.8
129
376
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.7
26.7
189
719
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
26.6
663
4209
J01AA02
ATC
doxycycline; systemic
1.4
26.5
3677
33049
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.0
26.5
369
1939
PH1AC
NOMESCO Finland
Flebography of over extremity with X-ray
4.7
26.5
92
200
69520
ICD-8 Finland
Erythematous condition, Erythema nodosum
18.3
26.1
40
22
M25.5
ICD-10 Finland
Pain in joint
1.5
26.0
1259
9359
GD1LA
NOMESCO Finland
GD
4.5
25.4
92
209
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
3.7
25.2
113
312
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
25.1
906
6309
ZXE00
NOMESCO Finland
One hour or less
1.4
25.0
1735
13783
GE1BE
NOMESCO Finland
Mediastinal ultrasound examinaiton through oesophagus
17.1
24.8
39
23
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.3
24.8
128
395
ZX120
NOMESCO Finland
Intravenous
1.8
24.7
436
2490
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.9
24.5
405
2264
I50.9
ICD-10 Finland
Heart failure, unspecified
1.7
24.3
502
3014
FPE37
NOMESCO Finland
Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes
12.0
24.2
44
37
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.0
24.1
343
1816
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
8.1
24.1
54
67
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
24.0
23
*
K77.8*D86.8
ICD-10 Finland
Hepatic granulomas in sarcoidosis
+∞
24.0
23
*
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
23.9
1124
8277
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
23.7
1046
7605
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
4.4
23.6
86
197
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
3.9
23.5
98
255
A02BC01
ATC
omeprazole; systemic
1.4
23.2
1198
8982
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
5.7
23.2
67
119
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.7
23.1
477
2863
1242
FHL
Bronchoscopy and transbronchial lung apia
230.9
22.6
23
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
22.5
1495
11727
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.0
22.3
310
1625
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
22.1
740
5051
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
22.0
585
3770
M04AA01
ATC
allopurinol; systemic
1.7
21.9
515
3208
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.1
21.8
261
1287
F1246
NOMESCO Finland
NA
17.1
21.7
34
20
I49.3
ICD-10 Finland
Ventricular premature depolarization
2.0
21.7
307
1619
J01DB01
ATC
cefalexin; oral
1.4
21.7
3811
34859
C03DA01
ATC
spironolactone; oral
1.7
21.2
454
2754
H26.3
ICD-10 Finland
Drug-induced cataract
6.1
21.0
57
94
A02BC03
ATC
lansoprazole; oral
1.4
20.9
1273
9809
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
20.7
880
6330
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
20.6
725
5003
XG405
NOMESCO Finland
Education on PEF monitoring
3.7
20.5
90
245
R03BA05
ATC
fluticasone; inhalant
1.5
20.5
756
5271
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.0
20.3
282
1477
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
4.9
20.3
66
135
ZXD05
NOMESCO Finland
Urgent procedure
1.4
20.3
1295
10050
M13.9
ICD-10 Finland
Arthritis, unspecified
1.9
20.3
323
1781
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
4.8
20.2
67
140
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
20.2
1721
14010
PJA10
NOMESCO Finland
Exploration of lymph nodes
4.3
20.2
75
176
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.9
20.2
324
1792
C01BD01
ATC
amiodarone; systemic
2.7
20.1
141
536
XCK10
NOMESCO Finland
Photography of fundus of eye
1.7
20.0
425
2568
H03AA01
ATC
levothyroxine sodium; systemic
1.4
19.9
983
7275
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
19.8
19
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.6
19.7
145
565
SPAT1262
SPAT
Handing over of treatment supplies
1.5
19.7
760
5346
JN4DR
NOMESCO Finland
Whole body metabolic PET with CT
14.6
19.3
32
22
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
19.2
2220
18877
201
Kela drug reimbursment
Chronic cardiac insufficiency
2.2
19.0
191
873
N18.8
ICD-10 Finland
Other chronic renal failure
2.8
19.0
125
457
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.8
18.9
325
1839
SPAT1263
SPAT
Sampling
1.3
18.8
1789
14768
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
3.5
18.8
87
249
R01AD09
ATC
mometasone; nasal
1.3
18.6
1928
16106
E66.01
ICD-10 Finland
Obesity due to excess calories
1.8
18.4
338
1954
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
18.4
1124
8635
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
18.3
469
2988
AS4
HP
Physiological pacemaker insertion DDD (R)
4.0
18.3
74
189
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
18.2
226
1134
D07AC01
ATC
betamethasone; topical
1.3
18.0
1456
11703
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
18.0
1387
11061
H22.1
ICD-10 Finland
Iridocyclitis in other diseases classified elsewhere
33.0
17.9
23
7
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
17.7
1371
10944
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
5.1
17.6
55
108
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
17.5
712
5055
J01CA04
ATC
amoxicillin; systemic
1.3
17.5
3643
33433
Z3231
NOMESCO Finland
Registered nurse
1.4
17.5
1151
8942
J01FF01
ATC
clindamycin; systemic
1.4
17.4
1158
9008
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
17.4
1746
14475
FPG96
NOMESCO Finland
Other implantation of permanent cardioverter-defibrillator
7.6
17.3
40
53
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
17.3
2466
21462
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.7
17.2
373
2270
R06.2
ICD-10 Finland
Wheezing
2.1
17.1
195
945
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
9.3
17.1
35
38
M81.4
ICD-10 Finland
Drug-induced osteoporosis
8.6
16.9
36
42
A02BC05
ATC
esomeprazole; systemic
1.3
16.8
1752
14587
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
16.8
416
2627
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
16.7
16
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
16.7
16
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
16.6
1548
12674
N02AX02
ATC
tramadol; systemic, rectal
1.3
16.6
1808
15142
1243
FHL
Bronchoscopy and other therapeutic procedure
27.6
16.5
22
8
JN4AD
NOMESCO Finland
Body CT examination
1.8
16.5
312
1823
R51.80
ICD-10 Finland
Headache
1.5
16.3
574
3945
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.4
16.1
817
6049
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.6
16.1
471
3101
207
Kela drug reimbursment
Chronic arrhythmias
1.5
16.1
538
3655
J01MA14
ATC
moxifloxacin; systemic
1.7
16.1
366
2258
B01AA03
ATC
warfarin; systemic
1.4
16.0
721
5217
T90
ICPC
Diabetes non-insulin dependent
1.4
16.0
928
7045
R05
ICPC
Cough
1.4
15.7
873
6571
R5140
NOMESCO Finland
Monitoring the use of the aid
1.6
15.7
441
2874
I44.0
ICD-10 Finland
Atrioventricular block, first degree
3.8
15.7
67
180
F2680
NOMESCO Finland
NA
11.2
15.7
29
26
TPH07
NOMESCO Finland
Cathetrisation of artery
1.6
15.6
408
2612
J01FA10
ATC
azithromycin; systemic
1.3
15.3
2504
22030
G51.0
ICD-10 Finland
Bell palsy
2.4
15.3
125
519
S18
ICPC
Laceration/cut
1.3
15.3
1753
14737
I51.4
ICD-10 Finland
Myocarditis, unspecified
5.3
15.1
45
85
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.7
15.0
346
2141
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
15.0
1731
14548
J01FA09
ATC
clarithromycin; systemic
1.3
15.0
1343
10902
I42.0
ICD-10 Finland
Dilated cardiomyopathy
2.5
14.9
120
496
ZX110
NOMESCO Finland
Intracutaneous
12.4
14.8
26
21
XW000
NOMESCO Finland
Bone marrow biopsy
2.1
14.8
164
785
E0000UV
ATC
NA
1.3
14.8
1614
13459
J45.8
ICD-10 Finland
Mixed asthma
2.3
14.8
133
579
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
14.7
473
3184
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
14.7
633
4539
TGW99
NOMESCO Finland
Other minor procedure in thoracic surgery
10.4
14.7
28
27
M63.3*D86.8
ICD-10 Finland
Myositis in sarcoidosis
+∞
14.6
14
*
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
+∞
14.6
14
*
CFA20
NOMESCO Finland
Biopsy of conjunctiva
11.9
14.5
26
22
WX110
NOMESCO Finland
Local anesthesy
1.3
14.5
3033
27425
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
5.1
14.5
45
89
AS8
HP
Physiological arrhythmia pacemaker insertionDDD (R) S
8.9
14.4
30
34
R03AC03
ATC
terbutaline; inhalant
1.5
14.4
579
4094
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
14.3
381
2454
R01AD12
ATC
fluticasone furoate; nasal
1.3
14.2
1199
9630
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.5
14.2
454
3054
B01AB05
ATC
enoxaparin; parenteral
1.3
14.2
1239
10006
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
2.5
14.2
108
433
A10BA02
ATC
metformin; oral
1.3
14.1
1091
8650
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
3.0
14.1
81
273
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
2.1
14.0
164
807
D07AD01
ATC
clobetasol; topical
1.4
14.0
632
4568
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.5
14.0
107
429
TFP00
NOMESCO Finland
Temporary use of transvenous or epicardial pacemaker
3.9
13.9
56
144
205
Kela drug reimbursment
Chronic hypertension
1.3
13.9
1060
8391
R42
ICD-10 Finland
Dizziness and giddiness
1.4
13.8
832
6337
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
13.8
630
4566
Z2221
NOMESCO Finland
Medical doctor
1.3
13.6
1132
9069
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.7
13.6
272
1618
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.6
13.6
375
2431
SPAT1153
SPAT
Removal of sutures
1.3
13.6
1318
10788
XF402
NOMESCO Finland
ECG with work load test
1.5
13.6
435
2925
H30.9
ICD-10 Finland
Chorioretinal inflammation, unspecified
12.0
13.6
24
20
E66.8
ICD-10 Finland
Other obesity
1.8
13.6
221
1230
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
5.5
13.5
39
71
G53.2
ICD-10 Finland
Multiple cranial nerve palsies in sarcoidosis
+∞
13.5
13
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
13.5
13
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
13.5
635
4630
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
13.4
640
4675
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.8
13.4
216
1196
D07AC13
ATC
mometasone; topical
1.3
13.3
1190
9628
H40.4
ICD-10 Finland
Glaucoma secondary to eye inflammation
13.8
13.2
22
16
C09AA05
ATC
ramipril; oral
1.3
13.2
949
7431
ZXA10
NOMESCO Finland
Bilateral
1.4
13.2
719
5380
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.4
13.2
106
439
C09DX04
ATC
valsartan and sacubitril; oral
4.4
13.0
46
105
A10AE04
ATC
insulin glargine; parenteral
1.6
13.0
369
2412
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
13.0
1561
13130
C08CA01
ATC
amlodipine; oral
1.3
13.0
1423
11829
A10BH01
ATC
sitagliptin; oral
1.6
12.9
368
2405
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
12.9
1038
8266
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
12.9
661
4893
XQ800
NOMESCO Finland
Prick test
1.6
12.7
298
1854
S97
ICPC
Chronic ulcer skin
1.8
12.7
206
1148
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.6
12.6
342
2210
A46
ICD-10 Finland
Erysipelas
1.4
12.6
547
3920
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
12.6
1129
9127
381
Kela drug reimbursment
Combination product containing sacubitril and valsartan
4.6
12.6
43
95
R05FB02
ATC
cough suppressants and expectorants
1.3
12.5
1569
13253
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
12.5
12
*
M05BA07
ATC
risedronic acid; oral
2.1
12.4
135
646
J01DA01
ATC
[U] cefalexin; systemic
1.2
12.4
2750
24807
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.5
12.3
466
3250
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.7
12.3
281
1735
289
Kela drug reimbursment
Combination product containing sacubitril and valsartan
4.0
12.3
48
121
WX402
NOMESCO Finland
General anaesthesia
1.4
12.3
663
4948
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.6
12.3
302
1906
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.5
12.2
455
3161
XF409
NOMESCO Finland
Other special ECG
4.7
12.2
40
85
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
12.2
1067
8592
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.7
12.2
263
1598
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
12.1
830
6442
WX002
NOMESCO Finland
Sedation and analgesia
1.4
12.1
774
5944
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.8
12.1
221
1277
6952A
ICD-9 Finland
Erythematous conditions, Erythema nodosum[ERYTHEMA NODOSUM ACUTUM]
18.1
12.0
18
10
A10BK03
ATC
empagliflozin; oral
1.7
12.0
273
1686
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.7
11.9
237
1407
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
11.9
521
3741
GDA10
NOMESCO Finland
Biopsy of lung
11.7
11.8
21
18
GX1K5
NOMESCO Finland
Diffusion capacity
8.9
11.7
24
27
R03AK11
ATC
formoterol and fluticasone; inhalant
2.2
11.7
112
504
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
11.7
240
1437
N19
ICD-10 Finland
Unspecified kidney failure
2.2
11.6
120
561
WW200
NOMESCO Finland
Immunization
2.2
11.6
120
562
J05AB01
ATC
aciclovir; systemic
1.3
11.6
823
6422
FM1CN
NOMESCO Finland
Heart perfusion isotope imaging at rest
18.9
11.6
17
9
Z3229
NOMESCO Finland
Other healthcare associate professional
1.6
11.5
325
2124
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
+∞
11.5
11
*
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
11.5
11
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.6
11.4
279
1755
J02AC01
ATC
fluconazole; systemic
1.3
11.4
1618
13832
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
3.7
11.4
49
135
H26.2
ICD-10 Finland
Complicated cataract
3.0
11.4
63
210
I50.1
ICD-10 Finland
Left ventricular failure
1.9
11.4
160
847
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.7
11.3
231
1385
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.5
11.3
426
2969
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
11.3
510
3685
A10AE05
ATC
insulin detemir; parenteral
1.7
11.2
219
1294
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.8
11.2
197
1130
K90.0
ICD-10 Finland
Coeliac disease
2.1
11.1
117
553
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.0
11.1
148
769
C09CA01
ATC
losartan; oral
1.3
11.1
944
7557
TFP34
NOMESCO Finland
Electrophysiological investigation
2.1
11.0
125
608
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.5
11.0
363
2454
FPJ24
NOMESCO Finland
Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes
11.1
11.0
20
18
R03DC03
ATC
montelukast; oral
1.4
11.0
624
4695
SPAT1325
SPAT
Vaccination
1.3
11.0
1294
10807
M05BB03
ATC
alendronic acid and colecalciferol; oral
2.4
11.0
94
404
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
10.9
412
2872
A10BH05
ATC
linagliptin; oral
1.9
10.9
160
860
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.2
10.9
56
178
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.7
10.8
225
1356
M79.6
ICD-10 Finland
Pain in limb
1.3
10.8
1440
12203
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
10.8
942
7565
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.7
10.8
202
1181
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
10.7
1176
9730
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
3.9
10.7
42
107
N03AX16
ATC
pregabalin; oral
1.3
10.7
941
7562
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
10.7
1568
13430
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.5
10.6
323
2148
J05AB11
ATC
valaciclovir; oral
1.4
10.6
504
3673
L04AD01
ATC
ciclosporin; systemic
2.4
10.6
86
361
5188X
ICD-9 Finland
Other diseases of lung
11.2
10.5
19
17
R60.0
ICD-10 Finland
Localized oedema
1.5
10.5
399
2787
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.2
10.4
104
480
A07AA02
ATC
nystatin; oral
1.7
10.4
233
1433
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
110.2
10.4
11
*
AA1AD
NOMESCO Finland
CT of head and brain
1.3
10.4
903
7243
A10BJ06
ATC
semaglutide; parenteral
2.0
10.3
133
682
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.4
10.3
427
3033
I50.0
ICD-10 Finland
Congestive heart failure
1.7
10.3
223
1359
R06.8
ICD-10 Finland
Other and unspecified abnormalities of breathing
2.8
10.2
64
230
J01MA02
ATC
ciprofloxacin; systemic
1.2
10.2
1563
13440
H47.1
ICD-10 Finland
Papilloedema, unspecified
4.9
10.2
32
66
S01EC01
ATC
acetazolamide; systemic
2.4
10.1
85
361
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
10.1
2202
19637
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
4.4
10.1
35
80
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.4
10.1
82
344
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
10.0
1136
9427
M10.9
ICD-10 Finland
Gout, unspecified
1.6
10.0
229
1417
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
1.8
9.9
173
989
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
3.2
9.9
50
158
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.3
9.8
816
6499
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.8
9.8
177
1022
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
2.7
9.8
66
249
R53
ICD-10 Finland
Malaise and fatigue
1.3
9.8
743
5847
XCH00
NOMESCO Finland
Eye pressure measurement
1.8
9.7
149
817
WX722
NOMESCO Finland
PEEP
1.7
9.7
180
1048
JN3AD
NOMESCO Finland
Abdominal CT examination
1.5
9.7
287
1898
NH3EA
NOMESCO Finland
Feet X-ray examination with load
2.3
9.7
89
398
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.5
9.6
324
2209
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
9.6
287
1905
M13.0
ICD-10 Finland
Polyarthritis, unspecified
2.9
9.6
55
188
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
6.0
9.5
25
42
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.9
9.5
139
752
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
1.8
9.5
152
846
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.6
9.5
217
1347
D64.9
ICD-10 Finland
Anaemia, unspecified
1.5
9.4
342
2365
M148, L529
ICD-10 Finland
NA
30.1
9.4
12
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.2
9.4
1943
17199
SPAT1255
SPAT
Intravenous administration of medicine
1.6
9.3
252
1628
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.4
9.3
423
3055
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
2.8
9.3
57
205
A03FA01
ATC
metoclopramide; systemic, rectal
1.3
9.3
801
6411
R01AD08
ATC
fluticasone; nasal
1.3
9.3
1152
9650
FM1DM
NOMESCO Finland
Heart very extensive MRI examination with 3 Tesla magnet
8.7
9.3
19
22
FPJ22
NOMESCO Finland
Revision of cardioverter-defibrillator with atrial and ventricular electrodes
9.5
9.2
18
19
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.0
9.2
108
537
GD1AA
SPAT
NA
1.6
9.2
262
1716
ZXD10
NOMESCO Finland
Scheduled procedure
1.2
9.2
1564
13565
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.0
9.2
118
609
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
9.2
437
3189
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
9.2
122
637
WX780
NOMESCO Finland
Remote monitoring CPAP
1.8
9.2
159
910
SPAT1310
SPAT
Counselling related to known health issue
1.2
9.1
1240
10493
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.6
9.1
242
1556
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.9
9.1
126
667
AN1
HP
Coronary angiography
1.4
9.0
414
3003
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.7
9.0
178
1059
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.6
8.9
218
1376
G44.2
ICD-10 Finland
Tension-type headache
1.4
8.8
477
3556
TQW80
NOMESCO Finland
Local dermatologic skincare
2.1
8.8
100
492
ZX108
NOMESCO Finland
Inhalation
3.8
8.8
35
92
Z94.1
ICD-10 Finland
Heart transplant status
7.2
8.7
20
28
A02BA02
ATC
ranitidine; systemic
1.3
8.7
749
5990
B01AF02
ATC
apixaban; oral
1.5
8.7
326
2272
I49.5
ICD-10 Finland
Sick sinus syndrome
1.9
8.7
128
694
D07AB02
ATC
hydrocortisone butyrate; topical
1.2
8.7
1092
9159
TFP20
NOMESCO Finland
Cardiodefibrillation
1.5
8.6
249
1639
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
2.6
8.6
61
240
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.4
8.6
361
2570
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
2.0
8.6
109
560
N06AX21
ATC
duloxetine; oral
1.4
8.6
403
2932
B01AB04
ATC
dalteparin; parenteral
1.7
8.5
176
1063
R01AD01
ATC
beclometasone; nasal
1.3
8.5
606
4720
P01AB01
ATC
metronidazole; oral, rectal
1.2
8.5
1611
14104
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.4
8.5
508
3853
K02.1
ICD-10 Finland
Caries of dentine
1.2
8.5
2350
21316
FPH10
NOMESCO Finland
Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator
7.3
8.4
19
26
R03BB04
ATC
tiotropium bromide; inhalant
1.4
8.4
339
2399
D84.8
ICD-10 Finland
Other specified immunodeficiencies
+∞
8.3
8
*
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
1.8
8.3
129
711
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
8.3
421
3105
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.7
8.3
175
1061
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
8.3
448
3343
01107
ICD-8 Finland
Pulmonary tuberculosis, Suspecta
7.1
8.2
19
27
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.7
8.2
152
889
H53.2
ICD-10 Finland
Diplopia
1.9
8.2
116
619
R02
ICPC
Shortness of breath/dyspnoea
1.4
8.2
419
3093
J47
ICD-10 Finland
Bronchiectasis
2.3
8.2
70
304
R06AE07
ATC
cetirizine; oral
1.2
8.1
1755
15533
S01ED51
ATC
timolol, combinations; ophthalmic
1.5
8.1
250
1672
N03AX12
ATC
gabapentin; oral
1.3
8.0
584
4559
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.2
8.0
1917
17126
F2682
NOMESCO Finland
NA
10.0
8.0
15
15
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.8
8.0
49
178
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.2
8.0
1658
14619
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.0
8.0
93
461
6BA02
NOMESCO Finland
NA
5.9
8.0
21
36
M01AE02
ATC
naproxen; oral, rectal
1.2
8.0
2372
21605
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.8
8.0
124
686
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.5
8.0
304
2129
M79.0
ICD-10 Finland
Rheumatism, unspecified
1.8
7.9
133
752
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
1.8
7.9
137
787
S01FA02
ATC
scopolamine; ophthalmic
2.9
7.9
46
161
XCK00
NOMESCO Finland
Perimetry
1.5
7.9
239
1592
H40.0
ICD-10 Finland
Glaucoma suspect
1.5
7.8
271
1858
N18.0
ICD-10 Finland
End-stage renal disease
2.9
7.8
46
162
R55
ICD-10 Finland
Syncope and collapse
1.4
7.8
367
2668
SPAT1097
SPAT
Recording of ECG
1.3
7.8
561
4373
UDC00
NOMESCO Finland
Ear microscopy
1.5
7.8
250
1684
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
2.0
7.8
94
472
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
3.7
7.8
32
87
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.3
7.8
563
4392
FPE40
NOMESCO Finland
Replacement of transvenous cardiac pacemaker electrode
4.6
7.8
25
54
L17
ICPC
Foot/toe symptom/complaint
1.2
7.8
938
7814
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
7.8
435
3262
XQ848
NOMESCO Finland
Dermatological photography
2.0
7.7
96
492
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
2.9
7.7
45
158
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
4.2
7.7
27
64
R04.0
ICD-10 Finland
Epistaxis
1.5
7.7
241
1618
I45.3
ICD-10 Finland
Trifascicular block
5.5
7.7
21
38
M54.5
ICD-10 Finland
Low back pain
1.2
7.7
1277
11012
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.8
7.6
114
624
M14.8*L52
ICD-10 Finland
Arthropathy in erythema: nodosum
25.0
7.6
10
*
R00.1
ICD-10 Finland
Bradycardia, unspecified
1.9
7.6
111
603
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
3.3
7.5
36
111
S01BA07
ATC
fluorometholone; ophthalmic (corticosteroids, plain)
2.2
7.5
69
312
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
7.5
960
8049
Z01.2
ICD-10 Finland
Dental examination
1.2
7.5
1604
14160
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.2
7.5
73
337
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
2.1
7.5
83
406
R03AC13
ATC
formoterol; inhalant
1.6
7.5
177
1109
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.0
7.4
92
471
A10BK01
ATC
dapagliflozin; oral
1.6
7.4
165
1016
SPAT1301
SPAT
No procedures
1.2
7.4
1188
10199
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
2.7
7.4
48
180
C07AB02
ATC
metoprolol; systemic
1.3
7.4
721
5853
S01BC03
ATC
diclofenac; ophthalmic
2.0
7.4
93
476
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
6.4
7.4
18
28
TK800
NOMESCO Finland
Hemodialysis
2.1
7.4
80
388
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.2
7.4
68
308
ASB
HP
Insertion of a biventricular physiological pacemaker DDD (R)
7.6
7.4
16
21
WX720
NOMESCO Finland
Own respiration
1.7
7.4
134
783
WX725
NOMESCO Finland
Noninvasive ventilation
1.6
7.4
166
1029
R06.5
ICD-10 Finland
Mouth breathing
1.4
7.3
325
2340
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
1.9
7.3
107
580
I89.9
ICD-10 Finland
Noninfective disorder of lymphatic vessels and lymph nodes, unspecified
8.4
7.3
15
18
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
7.3
7
*
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.3
7.3
470
3607
104
Kela drug reimbursment
Thyroid insufficiency
1.5
7.3
265
1837
R03BB01
ATC
ipratropium bromide; inhalant
1.8
7.2
116
649
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.4
7.2
303
2161
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
2.7
7.2
47
177
J96.1
ICD-10 Finland
Chronic respiratory failure
2.2
7.2
66
297
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.5
7.2
270
1886
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
2.0
7.2
88
450
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
2.4
7.2
55
228
127
Kela drug reimbursment
Transplant complication
2.3
7.2
63
278
L29
ICPC
Musculoskeletal sympt/complt other
1.5
7.2
254
1752
Y0499
ICD-8 Finland
Investigation of respiratory system
2.7
7.1
46
171
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
1.7
7.1
135
797
R04.2
ICD-10 Finland
Haemoptysis
1.8
7.1
119
677
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
7.1
2396
21968
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
2.6
7.1
48
186
UKC02
NOMESCO Finland
Cystoscopy
1.3
7.1
527
4126
SPAT1254
SPAT
Administration of medicine
1.3
7.1
494
3836
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
1.9
7.0
93
489
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.1
7.0
77
374
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
3.1
7.0
35
112
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.0
7.0
88
451
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.0
7.0
80
398
ZY010
NOMESCO Finland
Hospital outpatient
1.6
7.0
159
986
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.6
7.0
151
928
R5599
NOMESCO Finland
Other rehabilitation service
1.9
6.9
96
513
WX723
NOMESCO Finland
CPAP therapy
1.7
6.9
128
753
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
2.8
6.9
41
147
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
1.9
6.9
100
544
R06AE09
ATC
levocetirizine; oral
1.3
6.9
516
4044
FQA10
NOMESCO Finland
Orthotopic transplantation of heart with bicaval anastomosis
13.8
6.9
11
8
TFP52
NOMESCO Finland
Ablation treatment of ventricular tachycardia due to structural heart defect
13.8
6.9
11
8
H43.1
ICD-10 Finland
Vitreous haemorrhage
2.0
6.9
85
436
H3603, E103
ICD-10 Finland
NA
2.6
6.8
48
188
R03DA04
ATC
theophylline; systemic, rectal
1.6
6.8
159
998
A41.9
ICD-10 Finland
Sepsis, unspecified
1.8
6.8
114
650
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
9.3
6.8
13
14
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.1
6.8
75
366
D80.2
ICD-10 Finland
Selective deficiency of immunoglobulin A [IgA]
40.1
6.8
8
*
I42.8
ICD-10 Finland
Other cardiomyopathies
3.6
6.7
28
78
B07.9
ICD-10 Finland
Verruca simplex
1.7
6.7
119
690
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
6.7
1794
16111
A12BA01
ATC
potassium chloride; oral
1.7
6.7
140
853
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
1.9
6.7
96
520
UJF92
NOMESCO Finland
Capsular endoscopy
2.0
6.7
75
371
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.3
6.7
441
3395
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.7
6.7
136
822
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
3.5
6.7
29
84
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
2.7
6.7
41
151
Z49.1
ICD-10 Finland
Extracorporeal dialysis
2.5
6.7
48
193
R93.8
ICD-10 Finland
Abnormal findings on diagnostic imaging of other specified body structures
3.7
6.6
27
74
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.3
6.6
416
3178
A10BB12
ATC
glimepiride; oral
1.5
6.6
230
1582
C09CA06
ATC
candesartan; oral
1.2
6.6
806
6712
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.2
6.6
877
7376
H26.4
ICD-10 Finland
After-cataract
1.4
6.5
280
2008
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
2.2
6.5
59
265
J20
ICD-10 Finland
Acute bronchitis
1.4
6.5
338
2506
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
2.4
6.5
50
207
SPAT1229
SPAT
Assessment of need for aid
1.4
6.5
271
1930
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.4
6.5
51
215
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.3
6.5
517
4087
ZYC01
NOMESCO Finland
Remote contact by phone
1.6
6.5
151
947
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
6.5
627
5081
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.4
6.5
313
2293
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
6.5
981
8361
XG460
NOMESCO Finland
Short time oxymetry
2.2
6.4
63
292
I41.8*M05.3
ICD-10 Finland
Rheumatoid myocarditis
69.9
6.4
7
*
D59.9
ICD-10 Finland
Acquired haemolytic anaemia, unspecified
7.4
6.4
14
19
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.1
6.4
66
316
ZXE20
NOMESCO Finland
More than three and less than five hours
1.3
6.4
495
3899
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
4.7
6.4
20
43
I45.2
ICD-10 Finland
Bifascicular block
4.7
6.4
20
43
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
1.5
6.4
202
1361
GX1D5
NOMESCO Finland
Flow volume spirometry
8.1
6.3
13
16
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
8.1
6.3
13
16
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.0
6.3
70
346
N20.1
ICD-10 Finland
Calculus of ureter
1.6
6.3
134
821
H30.1
ICD-10 Finland
Disseminated chorioretinal inflammation
11.0
6.3
11
10
R99
ICPC
Respiratory disease other
2.1
6.3
63
299
I42.1
ICD-10 Finland
Obstructive hypertrophic cardiomyopathy
3.8
6.3
24
63
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
2.5
6.2
45
181
D80.6
ICD-10 Finland
Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
+∞
6.2
6
*
1230
FHL
Bronchomediastinoscopy
+∞
6.2
6
*
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
2.8
6.2
37
133
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.4
6.2
259
1849
GEA96
NOMESCO Finland
Other mediastinoscopic procedure
26.7
6.2
8
*
KBE12
NOMESCO Finland
Transluminal endoscopic extraction of calculus of ureter
2.6
6.2
41
157
R01BA52
ATC
pseudoephedrine, combinations; oral
1.2
6.2
1239
10834
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.6
6.2
136
840
XG466
NOMESCO Finland
Sleep oxymetry
1.7
6.2
121
725
C08CA02
ATC
felodipine; oral
1.4
6.2
303
2225
R20.2
ICD-10 Finland
Paraesthesia of skin
1.5
6.2
223
1549
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
1.9
6.2
86
463
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.5
6.2
174
1144
FPG30
NOMESCO Finland
Implantation of cardioverter-defibrillator with ventricular electrode
3.2
6.2
29
90
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
4.5
6.1
20
45
A07EC02
ATC
mesalazine; oral, rectal
1.5
6.1
195
1319
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.4
6.1
245
1732
A11CC03
ATC
alfacalcidol; systemic
1.9
6.1
77
399
A10BJ02
ATC
liraglutide; parenteral
1.9
6.1
87
471
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.5
6.1
219
1520
R03AC12
ATC
salmeterol; inhalant
1.6
6.1
143
900
JN6AD
NOMESCO Finland
CT of torso and neck
2.4
6.1
47
197
TQW99
NOMESCO Finland
Other minor procedure on skin
1.5
6.1
168
1099
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.0
6.0
72
364
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
4.4
6.0
20
46
A01AB09
ATC
miconazole; local oral
1.4
6.0
306
2262
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
0.1
6.0
*
232
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.5
6.0
169
1110
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42870588) Differential panel, method unspecified - Blood
2906
15560
2.82
308.57
9.0
5.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
3845
23065
3.17
307.65
9.4
5.9
e9/l
0.0
0.0
0.06
3513
19924
(3010838) Calcium [Moles/time] in 24 hour Urine
309
223
14.61
307.65
1.5
1.7
mmol/24h
5.5
8.3
1.49
18
15
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2876
1677
34.49
307.65
5.7
1.2
u/l
45.2
38.6
24.32
2742
1461
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
696
1433
5.41
307.65
2.4
2.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3928
22654
3.51
307.65
10.5
6.7
mmol/l
1.2
1.2
11.95
3368
19156
(3019198) Lymphocytes [#/volume] in Blood
3866
23612
3.10
307.65
9.5
5.9
e9/l
1.7
1.9
10.24
3560
20793
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3573
20542
3.07
307.65
8.6
5.9
mmol/l
1.2
1.2
11.32
3404
18636
(3013115) Eosinophils [#/volume] in Blood
3906
23865
3.15
307.65
9.7
6.1
e9/l
0.2
0.2
1.35
3593
20963
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
2203
999
35.89
307.65
5.1
1.2
mg/l
11.0
11.2
0.20
2143
913
(3001604) Monocytes [#/volume] in Blood
3833
22960
3.16
307.65
9.4
5.9
e9/l
0.6
0.6
0.03
3497
19836
(3022096) Basophils/100 leukocytes in Blood
3512
20857
2.86
303.00
9.7
6.1
%
0.8
0.7
13.24
3400
19462
(3018418) pH of Serum or Plasma
2626
13446
2.81
302.45
6.1
4.0
ph
7.4
7.4
0.25
537
2581
(3006504) Eosinophils/100 leukocytes in Blood
3556
21486
2.82
292.50
9.8
6.1
%
3.2
2.9
17.26
3434
20046
(3019069) Monocytes/100 leukocytes in Blood
3561
21610
2.81
289.00
10.1
6.4
%
9.3
8.6
38.56
3443
20263
(3018010) Neutrophils/100 leukocytes in Blood
3552
21865
2.73
274.22
9.5
6.0
%
58.3
57.2
8.58
3434
20463
(3002030) Lymphocytes/100 leukocytes in Blood
3581
22185
2.73
271.99
9.9
6.2
%
26.1
28.0
25.63
3462
20673
(3013650) Neutrophils [#/volume] in Blood by Automated count
4042
26683
2.89
269.73
12.0
9.2
e9/l
3.9
4.1
4.87
3719
23293
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
303
340
9.37
247.59
1.8
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
482
939
5.53
236.60
1.5
1.5
—
—
—
0
0
(3036603) Volume of Urine
267
273
10.22
233.65
2.1
1.5
ml
1909.9
1984.5
0.22
57
51
(3013707) Erythrocyte sedimentation rate by Westergren method
4585
34345
2.92
204.90
7.0
4.0
mm/h
12.8
12.0
3.65
4415
31884
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2233
12612
2.29
183.84
5.3
2.9
ng/l
1131.6
1304.9
1.57
1949
10758
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
324
563
6.05
178.85
1.1
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
4621
35788
2.73
173.76
10.9
7.6
u/l
78.1
78.0
0.09
4484
33764
(3009445) Proteinase 3 Ab [Units/volume] in Serum
606
1902
3.45
157.21
1.4
1.6
u/ml
25.9
9.3
0.64
13
46
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3439
24043
2.13
155.12
7.4
6.3
umol/l
11.5
11.4
0.32
3312
22822
(3015377) Calcium [Moles/volume] in Serum or Plasma
2488
15428
2.11
154.56
3.7
3.4
mmol/l
2.4
2.4
0.02
2261
13518
(3042631) Mycobacterium sp identified in Specimen
314
607
5.42
154.45
2.5
2.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
998
4215
2.67
152.59
2.4
2.2
nmol/l
342.6
371.1
5.33
950
3864
(3037522) Nuclear Ab [Titer] in Serum
1309
6365
2.38
147.63
1.4
1.3
titre
511.1
541.9
0.24
284
1329
(3005719) IgG [Mass/volume] in Serum or Plasma
853
3463
2.73
140.19
3.0
2.5
g/l
10.6
10.6
0.12
799
3155
(3032080) INR in Blood by Coagulation assay
2768
18383
2.01
137.06
9.8
8.8
inr
1.2
1.2
0.20
833
5355
(3024561) Albumin [Mass/volume] in Serum or Plasma
2895
19829
1.96
127.91
5.8
4.9
g/l
35.8
35.6
1.07
2727
18455
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
483
1525
3.37
123.20
1.6
1.7
titre
144.7
352.5
1.22
17
72
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2753
18824
1.92
119.24
2.8
2.2
nmol/l
73.9
77.6
10.38
2566
16985
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
174
241
7.42
118.98
1.4
1.0
u/l
1.2
1.1
0.76
94
124
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2558
17347
1.88
110.98
5.4
3.5
ng/l
30.4
77.3
1.05
1879
11615
(3021589) Normoblasts [#/volume] in Blood
2878
20289
1.87
110.16
13.8
9.5
e9/l
0.0
0.0
1.11
2481
16576
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
438
1411
3.28
107.80
1.7
1.6
iu/ml
0.3
7.1
0.92
91
307
(3011412) CD3 cells [#/volume] in Blood
214
405
5.46
107.45
2.4
2.4
e9/l
0.9
1.1
1.90
134
241
(3017181) Myelocytes/100 leukocytes in Blood
841
3908
2.36
101.67
5.1
4.2
%
0.9
0.9
0.38
240
1088
(3002179) Metamyelocytes/100 leukocytes in Blood
784
3566
2.40
99.35
4.9
4.0
%
0.6
0.6
0.15
182
776
(40760892) CBC W Ordered Manual Differential panel - Blood
1685
10267
1.92
99.15
7.0
4.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1000
5057
2.19
98.44
4.7
4.4
u/l
241.8
244.4
0.19
950
4797
(3021440) Promyelocytes/100 leukocytes in Blood
800
3718
2.35
96.34
5.2
4.2
%
0.1
0.2
1.38
224
1003
(3028026) IgM [Mass/volume] in Serum or Plasma
645
2726
2.55
95.69
1.8
1.8
g/l
1.2
1.3
1.90
600
2502
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
799
3748
2.32
94.02
4.8
2.8
ng/l
160.3
184.3
1.01
727
3398
(3025159) Blasts/100 leukocytes in Blood
759
3502
2.35
92.72
5.2
4.2
%
0.5
0.2
0.30
198
837
(3013826) Glucose [Moles/volume] in Serum or Plasma
3477
26955
1.78
88.11
6.3
4.7
mmol/l
6.8
6.7
1.07
3309
25282
(4010399)
714
3287
2.35
87.37
1.8
1.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
365
1197
3.19
86.86
1.4
1.5
iu/ml
10.6
17.3
—
8
30
(3012565) Volume of 24 hour Urine
143
230
6.36
84.97
1.8
2.3
ml
1971.3
1973.8
0.01
135
206
(1175426) CD3 cells/100 lymphocytes in Blood
169
324
5.35
83.58
2.3
2.0
%
69.5
72.8
1.58
162
308
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
166
315
5.40
83.03
2.2
2.0
%
15.0
14.7
0.08
70
126
(3005322) IgE [Units/volume] in Serum or Plasma
619
2828
2.34
76.58
1.4
1.3
u/ml
144.2
216.2
0.98
571
2618
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
430
1672
2.70
74.94
8.0
1.5
mg/l
3.8
3.8
0.04
387
1192
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
154
300
5.25
74.80
2.4
2.0
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
145
273
5.43
73.15
2.5
2.5
e6/l
395.9
529.4
1.78
127
225
(3037467) Urinalysis macro (dipstick) panel - Urine
3820
31172
1.72
72.99
5.3
4.2
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
139
257
5.52
71.52
2.5
2.6
e9/l
0.2
0.2
0.56
126
219
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1414
8893
1.79
70.98
6.3
3.6
ng/l
384.4
520.2
0.46
1111
6842
(40768795) Lymph node Pathology biopsy report
187
449
4.28
70.48
1.2
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2176
15438
1.67
70.46
4.0
3.3
u/l
31.7
35.9
2.10
2067
14659
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1102
6508
1.86
67.54
3.1
2.5
g/l
2.4
2.3
0.72
1048
6049
(3022948) Iron [Moles/volume] in Serum or Plasma
1171
7052
1.84
67.39
3.2
2.5
umol/l
13.1
13.3
0.45
1118
6569
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
243
724
3.46
67.32
1.2
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
325
1160
2.91
66.46
1.2
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
281
935
3.11
65.01
3.5
3.8
%
59.2
57.5
1.49
281
935
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
5128
46413
2.37
65.01
21.9
13.9
mg/l
19.3
23.4
20.18
4521
36725
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1032
6051
1.87
64.37
3.3
2.5
%
22.5
23.2
0.72
919
5199
(40758558) Short blood count panel - Blood
1730
11788
1.68
63.88
8.7
6.9
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1154
7024
1.81
63.70
2.6
2.1
s
29.8
29.8
0.00
1121
6821
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
719
3742
2.06
63.56
4.5
3.9
mmol/l
1.2
1.2
1.08
666
3278
(3044889) 12 lead EKG panel
3936
32937
1.67
62.50
5.1
3.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
144
309
4.76
62.50
1.2
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
236
737
3.30
60.65
1.6
1.6
g/l
0.8
0.8
0.14
166
569
(3023368) Bacteria identified in Blood by Culture
1751
12128
1.65
59.84
5.1
4.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1266
8054
1.74
59.50
1.3
1.3
iu/ml
34.7
32.4
0.20
412
2532
(3006184) Hemoglobin [Mass/volume] in Capillary blood
274
970
2.92
56.78
1.9
2.1
g/l
134.3
129.3
1.76
123
701
(21494815) CD4 cells/100 lymphocytes in Specimen
154
377
4.17
56.57
2.1
2.4
%
35.4
42.3
1.10
27
40
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
145
340
4.35
56.36
1.2
1.1
mg/l
41.9
40.1
0.20
120
284
(4062490)
170
450
3.87
56.10
1.5
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
93
150
6.29
55.11
2.0
2.1
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
168
451
3.81
54.34
1.4
1.3
g/l
0.4
0.4
1.14
111
324
(3028192) IgG subclass 2 [Mass/volume] in Serum
168
451
3.81
54.34
1.4
1.3
g/l
3.3
3.0
0.92
110
324
(3027135) IgG subclass 1 [Mass/volume] in Serum
168
452
3.80
54.17
1.4
1.3
g/l
7.0
6.9
0.06
109
322
(3019225) pH of Specimen
795
4519
1.89
53.81
6.9
4.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
970
5888
1.78
52.97
8.1
5.8
mmol/l
1.1
1.0
2.09
927
5489
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
138
328
4.29
52.71
1.1
1.1
mg/l
308.7
278.0
0.50
120
282
(3000492) Spirometry study
796
4559
1.87
52.53
2.0
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
634
3372
1.99
52.20
4.4
3.7
ng/l
87.0
90.2
0.27
569
2902
(3002582) Erythrocytes [#/volume] in Urine
1882
13645
1.57
51.39
3.8
3.2
e6/l
59.6
91.7
0.84
1520
10445
(3020630) Protein [Mass/volume] in Serum or Plasma
678
3713
1.94
51.22
2.1
2.6
g/l
66.7
66.6
0.08
640
3409
(3000850) Epithelial cells [#/volume] in Urine
1405
9505
1.64
51.21
3.1
2.5
e6/l
5.3
5.4
0.04
1261
8307
(3026493) Urate [Moles/volume] in Serum or Plasma
1742
12432
1.58
50.80
3.3
2.5
umol/l
3083.0
4332.8
0.74
1514
10827
(46235355) HIV 1 and 2 tests - Meaningful Use set
1086
6893
1.72
50.40
1.7
1.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
2126
15894
1.55
50.39
4.5
3.6
e6/l
78.6
99.2
0.47
1623
11279
(3007164) IgA [Mass/volume] in Serum or Plasma
1295
8638
1.65
49.69
1.6
1.4
g/l
2.4
2.5
0.68
869
5335
(3019550) Sodium [Moles/volume] in Serum or Plasma
5183
47889
2.23
49.54
24.0
15.8
mmol/l
139.7
139.7
0.73
5125
46757
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1251
8291
1.66
49.15
3.1
3.1
mmol/l
2.5
2.5
0.25
1126
7267
(4027681)
115
251
4.66
48.92
1.3
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2470
19159
1.52
48.89
4.0
2.8
ug/l
159.3
133.4
1.50
2323
17796
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1173
7655
1.67
48.89
1.3
1.3
u/ml
9.0
12.4
0.92
435
3039
(3023103) Potassium [Moles/volume] in Serum or Plasma
5192
48054
2.23
48.58
24.4
15.9
mmol/l
4.0
4.0
6.01
5130
46832
(3015171) Extractable nuclear Ab [Units/volume] in Serum
399
1834
2.27
47.94
1.2
1.2
u/ml
0.7
1.1
0.72
31
172
(3020779) Urea [Moles/volume] in Serum or Plasma
711
4043
1.87
47.69
10.7
7.6
mmol/l
10.1
9.6
1.26
684
3855
(3042936) Bacteria identified in Isolate by Culture
1019
6482
1.70
46.50
2.4
2.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
596
3229
1.95
46.25
2.4
2.4
au/ml
17.0
24.3
0.44
17
186
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
555
2940
1.99
45.96
1.3
1.3
au/ml
60.1
51.3
0.23
15
138
(36304419) Bacteria [Presence] in Urine
1692
12214
1.55
45.93
3.5
3.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
3503
29453
1.51
45.66
5.1
4.4
e6/l
1283.4
1583.8
0.17
52
399
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1145
7546
1.65
45.53
4.7
3.4
mmol/l
0.8
0.8
0.67
1088
7054
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
244
917
2.74
45.16
6.7
5.8
iu/ml
339.4
2192.9
0.58
38
134
(3009261) Glucose [Presence] in Urine by Test strip
2789
22421
1.49
45.03
4.3
3.6
estimate
0.0
0.0
0.62
600
3973
(3035350) Ketones [Presence] in Urine by Test strip
2757
22122
1.49
44.87
4.3
3.6
estimate
0.0
0.0
0.50
611
4002
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1940
14504
1.52
44.46
3.0
2.6
u/l
57.8
57.9
0.01
1805
13405
(3021601) Nitrite [Presence] in Urine by Test strip
2754
22172
1.48
43.56
5.7
4.8
estimate
0.0
0.0
0.30
623
4096
(3000494) Fungus identified in Specimen by Culture
890
5545
1.72
43.56
1.8
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1716
12541
1.53
43.53
3.7
3.1
e6/l
0.4
0.4
0.14
1347
9403
(21494814) CD8 cells/100 lymphocytes in Specimen
92
185
5.04
43.15
2.2
2.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
128
339
3.84
42.25
2.0
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1820
13557
1.51
41.82
3.8
3.2
mg/l
585.2
366.8
0.91
1208
8545
(3020682) Albumin/Creatinine [Ratio] in Urine
1896
14248
1.50
41.73
4.6
3.9
mg/mmol
9.5
8.8
0.29
1250
9030
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1454
10327
1.55
41.66
2.2
1.8
mg/l
1.3
1.2
0.54
1132
7874
(40768804) Tissue Pathology biopsy report
2399
18932
1.47
41.16
2.3
2.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1873
14079
1.50
40.99
2.4
2.2
u/l
203.7
222.6
0.18
1765
13242
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
316
1408
2.32
40.77
1.6
1.6
g/l
1.2
1.2
0.23
303
1332
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1084
7238
1.62
40.30
2.1
1.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1901
14379
1.49
40.13
3.8
3.1
mmol/l
7.5
7.7
1.08
1628
12170
(3004588) Protein electrophoresis panel - Serum or Plasma
554
3067
1.90
40.04
1.9
2.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
230
901
2.62
39.21
1.3
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
211
792
2.73
39.14
1.6
1.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
304
1357
2.31
39.04
1.6
1.6
g/l
0.2
0.2
0.63
292
1283
(3026782) Osmolality of Urine
1259
8773
1.56
38.84
3.2
2.7
mosm/kgh2o
537.9
545.1
0.60
1111
7470
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
315
1436
2.27
38.49
1.9
1.8
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
75
141
5.38
37.96
2.4
1.9
%
12.3
9.2
1.09
70
128
(3023419) Bacteria identified in Sputum by Culture
168
572
3.00
37.32
3.0
2.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
216
842
2.63
37.19
1.3
1.2
u/ml
286.0
274.0
0.24
142
525
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
138
423
3.32
36.58
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
232
946
2.52
36.41
1.5
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
257
1105
2.39
35.94
1.9
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
251
1074
2.40
35.48
2.0
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
4291
38408
1.52
35.35
25.2
16.8
%
13.8
13.7
2.90
4241
37594
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
186
695
2.73
34.82
3.2
2.6
u/ml
637.4
1381.1
0.59
11
42
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
205
808
2.60
34.52
1.5
1.4
u/ml
109.7
116.5
0.39
32
176
(3033658) Prothrombin time (PT) actual/Normal
1593
11908
1.47
34.50
4.8
4.0
%
90.9
90.9
0.00
1559
11616
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
263
1163
2.32
34.50
1.5
1.3
mg/l
642.3
533.0
0.54
251
1096
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
221
907
2.50
34.21
1.5
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
133
417
3.24
34.00
3.7
3.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
778
4974
1.66
33.87
1.6
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
4006
35495
1.46
33.52
4.6
4.0
pmol/l
14.9
14.8
4.45
3721
32461
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
172
632
2.78
33.26
1.6
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1489
11051
1.47
33.21
2.5
2.2
mg/l
3.2
3.0
2.59
1327
9468
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
237
1022
2.38
32.92
1.5
1.3
mmol/l
3.8
3.8
0.04
219
954
(3003396) Base excess in Arterial blood by calculation
804
5219
1.63
32.89
9.7
7.4
mmol/l
1.2
1.1
0.28
638
4080
(3048929) Epstein Barr virus Ab [Presence] in Serum
276
1272
2.23
32.81
1.3
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
871
5773
1.60
32.70
1.6
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
139
459
3.08
32.59
2.4
2.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
108
308
3.56
32.06
2.5
2.6
e6/l
438.8
672.6
3.47
65
124
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
236
1028
2.35
32.04
1.6
1.4
e6/l
61.4
26.7
0.29
181
786
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
236
1029
2.35
31.97
1.7
1.5
e6/l
259.3
1211.7
2.30
190
834
(4035726)
666
4148
1.69
31.94
1.5
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2587
21327
1.40
31.90
4.6
4.0
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
802
5247
1.62
31.69
9.8
7.4
kpa
5.0
5.1
0.97
756
5013
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
66
131
5.09
31.48
2.6
3.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
801
5247
1.62
31.47
9.8
7.4
kpa
11.9
12.4
1.99
757
5012
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
813
5356
1.61
31.18
2.7
2.8
umol/l
6.7
8.2
1.95
718
4676
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
767
4985
1.62
31.09
2.0
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
133
442
3.06
30.86
1.2
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
343
1762
2.01
30.70
2.3
1.9
ug/l
2.3
2.3
0.01
310
1582
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4624
42410
1.54
30.51
5.5
4.7
mu/l
2.0
2.1
0.81
4319
39021
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
482
2788
1.80
29.98
3.3
3.5
kpa
5.1
5.2
1.06
451
2586
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
280
1346
2.14
29.95
2.7
3.3
ratio
4.1
2.1
0.38
23
104
(3009343) pH of Capillary blood
476
2747
1.80
29.83
3.3
3.5
ph
7.4
7.4
0.72
72
344
(3034860) Kappa light chains.free [Mass/volume] in Serum
286
1390
2.11
29.73
2.7
3.3
mg/l
66.3
94.8
0.26
220
1127
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
285
1388
2.11
29.47
2.7
3.3
mg/l
45.2
56.9
0.40
220
1125
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
757
4965
1.61
29.45
1.9
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4683
43148
1.54
29.43
7.1
5.6
mmol/mol
41.1
39.7
16.15
4437
40104
(3027945) Reticulocytes/100 erythrocytes in Blood
748
4895
1.61
29.37
3.2
2.5
%
1.8
1.8
0.42
666
4357
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
164
634
2.64
28.75
1.8
1.6
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
61
124
4.96
28.33
1.5
1.9
u/l
16.7
60.0
1.39
55
117
(3007853) Bacteria identified in Skin by Aerobe culture
797
5341
1.57
28.22
2.1
1.8
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
673
4332
1.63
28.20
10.9
8.3
g/l
123.1
122.0
0.64
639
4169
(40768443) Skin Pathology biopsy report
375
2045
1.89
28.13
1.3
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
714
4679
1.60
27.77
10.5
7.8
%
95.9
95.7
0.37
677
4499
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
455
2646
1.78
27.73
3.3
3.4
mmol/l
2.0
1.8
0.54
346
1985
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
267
1301
2.11
27.57
1.2
1.3
u/ml
26.8
35.4
0.26
18
74
(3007566) Smooth muscle Ab [Titer] in Serum
272
1336
2.09
27.50
1.2
1.2
titre
85.2
161.0
0.77
25
106
(3034770) Mitochondria Ab [Titer] in Serum
271
1330
2.09
27.46
1.3
1.2
titre
548.0
1073.2
—
10
38
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2119
17195
1.38
27.31
4.5
3.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
156
607
2.62
27.01
1.4
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
214
963
2.27
26.96
1.2
1.2
u/ml
3.1
5.1
0.36
26
72
(3044640) Blood type and Crossmatch panel - Blood
1815
14387
1.39
26.89
2.8
2.4
—
—
—
0
0
(3013512) EKG study
1696
13292
1.40
26.89
4.6
3.8
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
45
73
6.21
26.58
1.1
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
169
692
2.49
26.33
1.4
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
223
1034
2.21
26.13
2.6
3.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
188
814
2.36
25.91
2.1
1.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
68
164
4.19
25.61
1.6
1.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
475
2864
1.72
25.45
7.4
6.9
mmol/l
24.8
24.5
0.61
434
2663
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
136
513
2.69
25.07
1.9
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
523
3253
1.67
24.95
1.4
1.4
—
—
—
0
0
(3012544) pH of Venous blood
642
4220
1.59
24.49
5.3
3.7
ph
7.4
7.4
—
5
24
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4736
44176
1.49
23.60
19.3
12.9
ml/min/173m2
79.0
81.5
13.23
4226
36702
(3023520) Reticulocytes [#/volume] in Blood
570
3676
1.61
23.50
2.9
2.6
e9/l
73.8
70.6
0.92
428
2760
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
141
560
2.56
23.46
1.2
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
488
3034
1.67
23.27
5.1
4.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
133
517
2.61
23.12
1.2
1.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
616
4063
1.58
23.09
5.3
3.7
kpa
5.8
5.8
0.77
592
3954
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
108
377
2.90
23.06
1.2
1.2
titre
179.5
143.6
0.21
19
74
(3004616) Nuclear Ab [Presence] in Serum
140
560
2.54
22.96
1.2
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
615
4063
1.58
22.88
5.3
3.7
mmol/l
1.7
2.0
0.83
507
3327
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
59
140
4.25
22.73
1.9
2.6
au/ml
125.1
153.5
—
9
24
(3041096) Erythrocytes [Presence] in Urine by Automated
1528
12038
1.37
22.65
3.9
3.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
810
5695
1.49
22.61
9.7
7.2
mmol/l
104.3
104.4
0.33
791
5580
(3029937) Albumin [Presence] in Urine by Test strip
1505
11873
1.37
22.00
4.8
4.0
estimate
0.0
0.0
2.14
609
3957
(3000991) Gas panel - Venous blood
568
3724
1.59
21.79
12.6
8.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
234
1190
2.01
21.54
1.2
1.3
u/ml
2.1
6.0
0.80
29
115
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
236
1207
2.00
21.38
1.2
1.3
u/ml
8.1
7.1
0.08
43
193
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
254
1335
1.95
21.27
1.7
1.7
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
31
43
7.24
21.18
1.1
1.1
u/l
29.2
22.6
0.46
22
30
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
455
2847
1.65
21.12
3.5
3.3
pmol/l
4.4
4.5
0.50
406
2537
(40768446) Kidney Pathology biopsy report
61
157
3.92
21.10
1.8
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
5203
49788
1.71
20.85
16.1
10.4
u/l
28.3
27.1
3.96
5115
48147
(3008536) Aspergillus sp Ab [Presence] in Serum
44
89
4.98
20.61
1.8
2.1
—
—
—
0
0
(44806118)
126
514
2.49
19.87
2.0
1.4
—
—
—
0
0
(44790049)
126
514
2.49
19.87
2.0
1.4
—
—
—
0
0
(44790047)
126
514
2.49
19.87
2.0
1.4
—
—
—
0
0
(44790048)
126
514
2.49
19.87
2.0
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
503
3276
1.59
19.80
1.8
1.6
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
44
95
4.66
19.11
2.2
1.8
e6/l
152.2
166.1
0.13
23
44
(40765096) Chromosome analysis panel by Banding
54
137
3.97
19.08
1.2
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
71
217
3.30
19.07
1.1
1.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
58
155
3.77
19.07
2.4
3.1
mg/l
6.4
7.7
0.84
35
122
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
402
2502
1.65
19.02
14.8
10.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1387
11012
1.35
18.94
2.8
2.3
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
33
56
5.92
18.67
7.2
5.7
ug/min
35.9
53.0
0.72
23
45
(3042733) HLA Ab [Presence] in Serum
55
144
3.85
18.62
4.1
4.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
630
4370
1.50
18.58
2.6
2.2
g/l
0.2
0.2
1.09
589
4094
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
244
1328
1.88
18.41
3.7
2.6
g/l
3.5
3.6
0.35
237
1260
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3498
31525
1.30
18.34
4.2
3.1
u/l
60.1
49.5
7.47
3286
29460
(3016018) Differential panel - Cerebral spinal fluid
119
492
2.45
18.27
1.5
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
334
2006
1.71
18.08
3.4
3.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
1597
13015
1.32
18.04
3.4
3.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
158
744
2.16
17.90
3.0
3.5
%
1.1
1.5
0.87
129
567
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
428
2750
1.60
17.80
9.7
7.5
mmol/l
24.7
24.9
0.35
428
2735
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
51
132
3.89
17.56
1.1
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
156
737
2.15
17.54
1.3
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
195
1001
1.98
17.53
3.2
3.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
114
472
2.44
17.46
4.2
3.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
5067
48436
1.53
17.26
19.3
13.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
662
4704
1.46
17.23
3.6
3.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
80
280
2.88
17.10
1.4
1.1
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
186
950
1.99
16.97
2.8
2.8
kpa
8.5
8.1
2.85
175
876
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
278
1615
1.76
16.95
1.9
2.3
g/l
10.4
10.2
0.29
234
1380
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
33
62
5.35
16.81
2.1
2.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
208
1110
1.91
16.70
3.0
3.1
mmol/l
24.6
24.9
0.46
183
963
(3021901) Oxygen saturation in Capillary blood
162
792
2.08
16.68
2.8
2.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1306
10453
1.33
16.51
4.1
3.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
292
1736
1.72
16.41
1.9
2.2
g/l
3.7
3.8
0.56
215
1264
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
292
1736
1.72
16.41
1.9
2.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
292
1737
1.72
16.38
1.9
2.2
g/l
7.2
7.4
0.73
220
1322
(3017732) Neutrophils [#/volume] in Blood
480
3227
1.53
16.35
2.7
2.9
e9/l
4.2
4.1
0.29
399
2544
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
323
1976
1.67
16.33
1.9
1.7
g/l
1.5
1.6
0.47
271
1706
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
69
230
3.03
16.10
1.3
1.3
%
38.8
66.4
—
5
27
(3019309) Folate [Moles/volume] in Red Blood Cells
1053
8192
1.35
16.08
1.8
1.7
nmol/l
1173.3
1169.1
0.05
826
6232
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
61
190
3.24
15.95
1.2
1.1
ng/l
547.8
442.3
0.07
18
43
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
67
222
3.04
15.80
5.3
4.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
185
969
1.94
15.72
1.2
1.2
u/ml
41.2
46.1
0.19
29
104
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
995
7698
1.36
15.72
3.1
2.7
e6/l
1.1
1.1
0.07
586
4342
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
111
477
2.35
15.70
1.2
1.2
u/l
55.4
59.3
0.30
85
322
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
220
1221
1.83
15.64
3.3
3.1
mg/l
1.7
1.5
2.60
202
1130
(3010375) cycloSPORINE [Mass/volume] in Blood
63
203
3.13
15.58
28.2
27.2
ug/l
122.5
117.3
0.22
52
171
(3008898) HLA-B27 [Presence]
267
1573
1.73
15.51
1.1
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
275
1634
1.72
15.50
1.9
2.3
g/l
3.0
3.1
0.92
218
1294
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
551
3857
1.48
15.43
3.2
2.6
ml/min/173m2
60.7
67.4
4.11
246
1507
(3027273) Bicarbonate [Moles/volume] in Venous blood
331
2069
1.64
15.39
4.1
3.4
mmol/l
25.2
25.3
0.45
313
2010
(40768797) Stomach Pathology biopsy report
854
6475
1.38
15.29
1.3
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
42
105
4.02
15.20
1.5
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
52
151
3.47
15.19
1.5
1.7
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
90
359
2.53
14.98
1.2
1.2
u/ml
109.0
66.7
—
10
15
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1225
9831
1.32
14.98
1.3
1.3
u/ml
2.1
1.8
0.20
323
2682
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
430
2877
1.54
14.96
12.9
9.3
%
0.7
0.7
0.37
425
2858
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
134
637
2.13
14.88
1.1
1.1
g/l
1.5
1.5
0.28
127
575
(3048689) Calprotectin [Mass/mass] in Stool
734
5457
1.40
14.76
2.2
2.3
ug/g
158.5
135.9
0.59
588
4351
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
90
363
2.50
14.65
1.2
1.2
u/ml
50.6
39.5
—
10
29
(3039162) Centromere protein B Ab [Units/volume] in Serum
124
576
2.18
14.61
1.2
1.3
u/ml
69.1
48.7
0.33
12
35
(3022145) Colonoscopy Study observation
709
5252
1.40
14.56
1.3
1.3
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
429
2892
1.52
14.41
12.6
9.2
%
1.4
1.4
0.10
423
2878
(40761536) Microorganisms panel - Urine sediment
537
3792
1.46
14.35
4.6
3.9
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
86
343
2.53
14.34
1.2
1.2
u/ml
1.9
3.5
—
9
25
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
53
162
3.29
14.32
1.7
1.9
u/ml
688.0
23056.4
—
6
22
(3051651) Icteric interference index of Serum or Plasma
73
269
2.74
14.25
3.8
3.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2144
18550
1.25
14.20
2.1
2.0
pmol/l
96.4
95.9
0.17
1127
9629
(3007930) Methemoglobin/Hemoglobin.total in Blood
296
1838
1.64
14.14
6.3
5.3
%
1.0
0.9
1.45
266
1715
(3026250) Tacrolimus [Mass/volume] in Blood
58
189
3.09
14.11
42.9
34.6
ug/l
7.9
7.5
0.66
53
174
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
251
1493
1.71
14.11
4.1
3.2
u/ml
0.4
0.3
0.29
142
851
(3014007) Fractional oxyhemoglobin in Arterial blood
429
2905
1.52
14.11
12.9
9.3
%
94.1
94.0
0.17
429
2895
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
72
265
2.74
14.09
2.8
2.5
%
42.0
40.0
0.33
40
83
(3038026) Centromere Ab [Units/volume] in Serum
90
370
2.46
14.08
1.2
1.2
u/ml
72.6
62.9
—
6
18
(3024932) HLA-DR beta [Type]
50
149
3.38
14.06
1.2
1.1
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
20
27
7.43
13.97
1.3
1.1
u/l
2.0
6.0
—
8
6
(40767503) Oxygen content in Capillary blood by calculation
179
968
1.88
13.85
2.5
2.4
%
17.4
16.3
2.75
99
479
(3017354) Segmented neutrophils/100 leukocytes in Blood
103
455
2.29
13.73
3.0
3.5
%
61.6
58.6
0.60
74
285
(3045142) Bone marrow Pathology biopsy report
113
519
2.20
13.72
1.5
1.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
296
1853
1.63
13.70
6.3
5.2
%
1.7
1.7
0.17
267
1725
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4759
45301
1.35
13.51
5.1
4.5
mmol/l
6.1
5.9
6.61
4446
41558
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1200
9722
1.30
13.49
1.7
1.7
pmol/l
3689378.8
33714364.5
4.81
1003
8145
(3047181) Lactate [Moles/volume] in Blood
243
1451
1.71
13.48
7.4
6.2
mmol/l
1.4
1.3
0.65
212
1269
(3052851) Hemolysis interference index of Serum or Plasma
231
1362
1.73
13.42
3.3
3.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
168
900
1.89
13.40
1.6
1.6
—
—
—
0
0
(3010421) pH of Blood
213
1228
1.76
13.39
3.4
4.4
ph
7.4
7.4
0.88
186
1025
(3014111) Lactate [Moles/volume] in Serum or Plasma
554
3994
1.43
13.22
11.1
7.2
mmol/l
1.4
1.3
0.81
538
3858
(3024354) Oxygen [Partial pressure] in Venous blood
475
3327
1.47
13.22
3.9
3.1
kpa
4.6
4.6
0.08
456
3224
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
279
1738
1.64
13.17
3.6
3.7
mmol/l
25.1
24.9
0.83
256
1616
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
912
7139
1.33
13.10
3.5
2.9
e6/l
2.9
2.6
0.33
504
3806
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
75
293
2.58
13.08
1.5
1.5
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
187
1046
1.82
13.02
3.5
4.5
kpa
8.5
8.6
0.34
187
1031
(3012501) Base excess in Blood by calculation
186
1039
1.82
13.01
3.5
4.4
mmol/l
2.3
2.6
0.90
133
722
(3013290) Carbon dioxide [Partial pressure] in Blood
186
1040
1.82
12.97
3.5
4.4
kpa
4.9
5.0
1.72
186
1026
(40768441) Liver Pathology biopsy report
86
361
2.40
12.89
1.2
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
49
153
3.22
12.83
1.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
101
456
2.24
12.81
1.9
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
158
845
1.90
12.69
3.5
3.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
765
5863
1.35
12.63
26.1
23.2
inr
1.4
1.3
0.49
127
871
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
86
365
2.38
12.59
1.5
1.6
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
222
1319
1.71
12.56
3.9
2.5
%
203.9
191.5
1.17
200
1255
(3042111) Morphology [Interpretation] in Bone marrow Narrative
145
765
1.92
12.15
1.5
1.6
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
78
323
2.44
12.07
1.1
1.0
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
219
1312
1.70
12.03
2.1
2.2
g/l
0.0
0.0
0.20
199
1217
(3006922) Hepatitis E virus Ab [Presence] in Serum
81
342
2.39
12.02
1.0
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
113
548
2.08
12.00
1.4
1.9
—
1296.0
—
0
25
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
78
324
2.43
11.99
1.1
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
147
783
1.90
11.97
1.1
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
539
3935
1.41
11.96
2.6
2.3
ug/l
11.4
7.7
1.30
489
3487
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
948
7554
1.31
11.90
1.5
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
67
261
2.59
11.79
1.5
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
67
261
2.59
11.79
1.5
1.6
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
392
2704
1.48
11.78
4.5
3.2
g/l
127.5
129.8
1.12
379
2636
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
46
146
3.17
11.75
1.2
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
162
896
1.83
11.74
1.5
1.6
—
—
—
0
0
(4015189)
39
112
3.50
11.66
2.1
2.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
208
1247
1.69
11.42
1.3
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
319
2128
1.53
11.26
6.2
3.9
mmol/l
23.9
24.2
0.87
291
1926
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
203
1215
1.70
11.22
2.1
2.2
g/l
0.0
0.0
0.00
184
1136
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
204
1229
1.69
11.01
2.1
2.2
g/l
0.0
0.0
0.00
184
1137
(3018405) Lactate [Moles/volume] in Arterial blood
253
1611
1.60
10.97
3.6
3.8
mmol/l
1.4
1.4
0.04
248
1588
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
119
609
1.97
10.94
9.5
6.7
mg/l
11.9
11.7
0.20
108
567
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
196
1172
1.70
10.88
1.2
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
352
2415
1.49
10.87
14.1
9.7
mmol/l
24.4
24.3
0.17
329
2269
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
232
1451
1.63
10.83
3.4
2.2
%
94.8
91.8
1.23
217
1351
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
104
509
2.06
10.82
2.3
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
512
3771
1.39
10.78
4.1
3.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
46
154
3.00
10.77
1.2
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
407
2879
1.45
10.75
1.5
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
149
826
1.83
10.75
1.4
1.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
236
1486
1.61
10.72
2.2
2.3
g/l
0.7
0.9
0.37
206
1301
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
25
55
4.56
10.69
1.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
43
139
3.11
10.69
1.2
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
369
2570
1.47
10.57
1.6
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
204
1243
1.67
10.56
1.4
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
629
4806
1.35
10.52
3.5
4.1
ug/l
10.7
25.8
1.66
469
3876
(40758047) Lysozyme [Mass/volume] in Pleural fluid
23
48
4.81
10.47
1.0
1.2
mg/l
12.9
9.1
0.50
15
43
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
137
748
1.85
10.39
1.2
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
218
1359
1.63
10.33
2.0
2.1
g/l
38.4
37.8
0.73
196
1184
(3021960) Folate [Moles/volume] in Serum or Plasma
1229
10277
1.25
10.30
1.6
1.5
nmol/l
20.1
20.6
0.48
1056
8836
(3039000) Anion gap in Blood
177
1046
1.71
10.28
8.3
7.2
mmol/l
11.1
11.3
0.23
150
931
(3018572) Chloride [Moles/volume] in Blood
177
1047
1.71
10.24
8.3
7.2
mmol/l
105.1
105.1
0.04
150
932
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
55
210
2.64
10.13
1.2
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
219
1376
1.62
10.06
3.7
4.1
mmol/l
3.9
3.9
0.36
199
1304
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
142
793
1.81
10.03
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
276
1838
1.53
9.85
4.3
4.6
—
—
—
0
0
(3036489) Thrombin time
263
1734
1.54
9.83
3.2
2.1
s
22.4
21.5
1.09
225
1510
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
245
1590
1.57
9.82
3.3
2.3
ug/l
500.9
690.2
0.36
230
1500
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
121
648
1.89
9.77
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
411
2966
1.42
9.73
1.2
1.2
iu/ml
133.3
144.3
0.24
158
1097
(3017704) Immunofixation for Urine
60
244
2.47
9.73
1.2
1.6
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
65
276
2.37
9.61
1.1
1.1
nmol/l
2.5
6.1
0.65
13
61
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
63
264
2.40
9.59
1.1
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1155
9659
1.25
9.58
4.6
4.0
kg/l
1.0
1.0
0.11
179
1403
(3047007) Chlamydophila sp Ab [Presence] in Serum
119
639
1.88
9.54
1.2
1.2
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
43
149
2.90
9.52
1.4
1.2
%
30.8
19.2
—
8
19
(3007461) Platelets [#/volume] in Blood
5294
51706
1.51
9.49
32.0
20.4
e9/l
248.8
251.6
2.32
5222
50476
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
95
474
2.02
9.43
2.4
1.7
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
183
1121
1.65
9.32
1.7
1.6
e6/l
10881.8
12110.1
0.27
142
804
(3024731) MCV [Entitic volume]
5295
51732
1.50
9.31
31.8
20.4
fl
90.7
91.1
6.67
5261
51051
(3035941) MCH [Entitic mass]
5295
51734
1.50
9.29
31.8
20.3
pg
30.2
30.3
9.87
5260
51050
(3026361) Erythrocytes [#/volume] in Blood
5295
51739
1.50
9.23
31.9
20.4
e12/l
4.5
4.5
3.27
5220
50365
(3000963) Hemoglobin [Mass/volume] in Blood
5295
51749
1.50
9.10
32.1
20.5
g/l
136.1
136.2
0.35
5260
51070
(3010813) Leukocytes [#/volume] in Blood
5295
51752
1.50
9.07
32.0
20.5
e9/l
6.6
6.7
2.90
5211
50366
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
77
363
2.14
8.91
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
77
363
2.14
8.91
1.2
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
94
478
1.98
8.88
1.1
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
91
458
2.00
8.85
3.8
3.5
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
77
364
2.13
8.85
1.2
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
66
294
2.26
8.77
1.6
1.5
u/l
7.1
5.8
0.25
34
141
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
207
1329
1.58
8.73
1.4
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
365
2631
1.41
8.72
1.8
1.7
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
77
367
2.11
8.67
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
77
367
2.11
8.67
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
77
367
2.11
8.67
1.2
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
57
240
2.39
8.62
1.2
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
568
4400
1.32
8.61
2.6
2.5
u/l
40.0
48.7
0.35
477
3792
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
3142
29090
1.18
8.59
3.0
2.9
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
27
75
3.61
8.54
1.2
1.6
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
28
80
3.51
8.50
1.8
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
88
447
1.98
8.36
1.2
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
127
730
1.76
8.22
1.3
1.2
u/ml
3.2
3.5
0.09
39
233
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
82
409
2.02
8.21
1.2
1.3
titre
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
72
342
2.12
8.20
1.3
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
229
1528
1.52
8.16
3.3
3.1
g/l
0.3
0.3
0.12
106
639
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
290
2032
1.45
8.10
4.0
2.7
%
0.7
0.6
0.36
281
1949
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
81
405
2.01
8.06
2.0
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
81
405
2.01
8.06
2.0
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
81
405
2.01
8.06
2.0
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
163
1013
1.63
7.91
1.4
1.5
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
68
321
2.13
7.89
1.5
1.3
u/ml
0.9
0.9
0.03
35
141
(3025941) Bacteria identified in Stool by Culture
351
2560
1.40
7.85
1.3
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
87
453
1.94
7.73
1.2
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
321
2313
1.41
7.71
3.8
2.7
e6/l
0.2
0.3
1.55
312
2254
(3028679) Herpes simplex virus Ab [Presence] in Serum
50
210
2.39
7.65
1.1
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
122
713
1.73
7.48
1.3
1.2
u/ml
3.9
4.5
0.16
53
304
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
142
865
1.66
7.47
1.3
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
274
1930
1.44
7.47
4.0
3.9
%
45.4
49.3
1.79
269
1907
(21494890) Protein electrophoresis panel - 24 hour Urine
86
452
1.92
7.45
1.7
2.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
62
289
2.16
7.45
1.2
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
108
611
1.78
7.42
2.0
1.8
%
89.8
89.7
0.09
108
604
(3009214) Lutropin [Units/volume] in Serum or Plasma
177
1143
1.57
7.34
1.4
1.4
u/l
11.5
10.6
0.31
149
935
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
55
247
2.24
7.24
1.2
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
59
273
2.17
7.23
3.3
2.0
min
502.5
493.9
0.33
49
202
(3009542) Hematocrit [Volume Fraction] of Blood
4431
42524
1.21
7.18
22.2
14.8
%
40.0
40.1
0.13
3149
31018
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4640
44748
1.22
7.06
4.3
3.9
mmol/l
1.4
1.3
15.99
4326
41166
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
98
547
1.81
7.06
1.5
1.6
%
51.1
58.4
0.82
55
339
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
13
23
5.66
7.06
1.8
1.2
mg/l
6.3
5.3
—
5
14
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
13
23
5.66
7.06
1.8
1.2
mg/l
3.1
3.6
—
6
14
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
13
23
5.66
7.06
1.8
1.2
mg/l
0.7
1.6
—
6
14
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
13
23
5.66
7.06
1.8
1.2
mg/l
4.8
2.3
—
6
17
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
13
23
5.66
7.06
1.8
1.2
mg/l
5.2
3.4
—
6
17
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
13
23
5.66
7.06
1.8
1.2
mg/l
6.4
1.4
—
7
16
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
13
23
5.66
7.06
1.8
1.2
mg/l
8.9
4.4
—
8
17
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
13
23
5.66
7.06
1.8
1.2
mg/l
5.3
2.7
—
6
18
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
81
427
1.91
6.98
1.4
1.5
%
33.6
31.3
0.20
50
255
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
119
705
1.70
6.98
1.2
1.1
%
119.6
116.4
0.37
105
644
(3027456) Digoxin [Moles/volume] in Serum or Plasma
132
804
1.66
6.98
2.9
3.1
nmol/l
0.9
0.8
0.66
95
613
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
36
135
2.68
6.97
1.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
122
728
1.69
6.97
1.2
1.1
—
—
—
0
0
(4268621)
91
499
1.84
6.95
2.4
2.3
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
95
528
1.81
6.95
1.2
1.1
%
99.8
95.9
0.61
87
498
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
103
588
1.77
6.89
1.5
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1395
12227
1.19
6.89
1.4
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
264
1880
1.42
6.81
2.2
1.9
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
46
197
2.35
6.78
1.2
1.1
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
13
24
5.43
6.76
1.8
1.3
mg/l
2.9
1.8
—
6
16
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
101
578
1.76
6.71
1.5
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
46
198
2.33
6.71
1.1
1.1
miu/ml
1551.6
1504.6
0.11
46
198
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
245
1727
1.44
6.69
1.9
1.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4806
46571
1.24
6.68
4.8
4.4
mmol/l
4.7
4.7
4.26
4536
43369
(3004775) Volume in Urine collected for unspecified duration
71
366
1.95
6.56
3.2
2.1
ml
679.0
632.2
0.48
57
247
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
165
1080
1.54
6.50
3.2
2.3
ug/min
135.9
103.4
0.30
103
661
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
99
571
1.75
6.42
1.5
1.4
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
107
632
1.71
6.38
1.4
1.4
mu/l
101.4
51.7
0.67
91
560
(3005988) Vibrio sp identified in Specimen by Organism specific culture
99
573
1.74
6.35
1.5
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
100
581
1.73
6.33
1.5
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4772
46267
1.22
6.23
4.7
4.4
mmol/l
1.4
1.5
32.36
4466
42881
(3025468) Yersinia sp identified in Specimen by Organism specific culture
98
570
1.73
6.19
1.5
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
105
624
1.70
6.14
1.6
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
22
67
3.29
6.12
1.5
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
77
420
1.85
6.03
1.2
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
58
289
2.02
5.93
1.7
1.6
u/l
5.8
6.7
0.60
46
249
(3016135) IgD [Mass/volume] in Serum
9
6
15.02
5.90
3.7
1.3
mg/l
36.9
131.9
—
9
6
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
9
6
15.02
5.90
1.1
1.0
mg/l
2.3
1.2
—
9
6
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4871
47375
1.23
5.87
5.3
4.9
mmol/l
2.8
2.8
2.83
4569
43911
(3002256) Pathology report gross observation
718
5994
1.23
5.86
1.3
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
44
198
2.23
5.84
1.1
1.1
iu/ml
236.5
164.7
0.56
44
198
(3035637) Corticotropin [Mass/volume] in Plasma
96
565
1.71
5.84
1.5
1.6
—
—
—
0
0
(3004451) EKG impression Narrative
48
224
2.15
5.83
1.3
1.3
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
70
376
1.87
5.77
1.0
1.0
mg/l
314.1
286.4
2.25
65
342
(3044927) Protein electrophoresis panel - Urine
79
443
1.79
5.69
1.1
1.2
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
52
253
2.07
5.68
1.3
1.4
nmol/l
1.2
1.2
0.07
37
195
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
39
169
2.32
5.66
1.1
1.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
69
372
1.87
5.63
1.9
1.9
g/24h
0.9
1.0
—
6
21
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
18
51
3.54
5.59
10.7
12.8
mmol/l
4.5
5.9
2.22
18
51
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
136
887
1.55
5.50
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
136
887
1.55
5.50
1.3
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
187
1305
1.45
5.45
1.4
1.3
—
—
—
0
0
(4306422)
115
727
1.59
5.34
1.3
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
37
161
2.31
5.33
2.2
2.0
ug/l
59.7
60.7
0.02
37
156
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
153
1036
1.49
5.22
1.4
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
17
49
3.48
5.16
1.4
2.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
19
59
3.23
5.16
6.7
5.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
48
237
2.03
5.08
2.4
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
48
237
2.03
5.08
2.4
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
48
237
2.03
5.08
2.4
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
48
237
2.03
5.08
2.4
1.9
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
12
27
4.45
5.03
2.0
2.0
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
149
1012
1.49
5.02
2.7
3.0
umol/l
32.1
36.1
1.06
134
870
(3036670) Protein [Mass/volume] in Synovial fluid
31
129
2.41
4.95
1.4
1.2
g/l
39.7
38.7
0.15
16
70
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
54
281
1.93
4.95
1.1
1.2
ratio
1.0
1.0
0.91
17
106
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
22
78
2.83
4.81
2.2
1.5
ng/l
119.4
137.8
0.24
22
78
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
146
999
1.47
4.76
3.1
3.5
u/ml
305.0
616.6
0.43
129
906
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
28
114
2.46
4.70
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
28
114
2.46
4.70
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
28
114
2.46
4.70
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
28
114
2.46
4.70
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
74
433
1.72
4.67
1.6
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
311
2421
1.30
4.63
2.5
2.4
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
74
435
1.71
4.60
1.2
1.3
nmol/l
1.6
1.4
0.60
64
392
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
158
1106
1.44
4.59
1.8
1.8
iu/l
4.9
4.7
0.09
57
407
(21494434) Karyotype in Bone marrow
70
409
1.72
4.46
1.2
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
585
4930
1.21
4.35
1.6
1.6
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
112
741
1.52
4.33
1.2
1.1
iu/ml
4.9
14294.1
0.54
25
164
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
16
50
3.21
4.33
1.1
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
170
1221
1.40
4.31
1.3
1.3
miu/ml
205.3
212.3
0.07
49
558
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
301
2362
1.29
4.25
3.5
3.4
u/ml
50.9
57.5
0.21
286
2274
(3003434) Protein [Mass/volume] in Pleural fluid
89
563
1.59
4.20
1.7
1.5
g/l
31.1
33.3
0.93
81
507
(3045424) Erythrocytes [Presence] in Urine
117
787
1.50
4.20
1.6
1.5
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
13
36
3.62
4.20
1.2
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
21
79
2.66
4.15
1.3
1.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
30
134
2.25
4.14
2.1
1.5
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
23
91
2.53
4.12
2.4
1.6
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
79
489
1.62
4.09
7.6
18.5
mmol/l
8.3
7.3
1.02
66
409
(3000570) Elastase.pancreatic [Mass/mass] in Stool
189
1396
1.37
4.07
1.4
1.4
ug/g
285.4
275.4
0.25
110
801
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
92
592
1.56
4.06
1.2
1.3
pmol/l
462.0
327.8
0.36
62
454
(3010144) Erythrocytes [#/volume] in Synovial fluid
71
429
1.66
4.04
1.4
1.4
e6/l
150661.1
90503.8
0.33
60
300
(3019174) dRVVT (LA screen)
14
42
3.34
4.04
1.1
1.2
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
45
238
1.90
4.00
1.1
1.1
u/l
92.3
82.4
0.43
35
187
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
16
53
3.02
3.96
1.2
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
81
509
1.60
3.96
1.4
1.3
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
17
59
2.89
3.89
1.2
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
20
76
2.64
3.89
1.1
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
219
1672
1.32
3.81
3.1
3.5
u/ml
642.4
3255.8
0.88
183
1431
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
15
49
3.07
3.80
1.1
1.3
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
11
29
3.80
3.80
1.2
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
47
257
1.84
3.79
1.3
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
257
2008
1.29
3.78
1.3
1.3
iu/l
30.9
31.1
0.03
214
1743
(36660697) Celiac disease serology panel - Serum
430
3568
1.22
3.77
1.2
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
70
431
1.63
3.73
1.6
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
79
503
1.58
3.68
2.3
2.3
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
16
56
2.86
3.62
1.6
2.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
16
56
2.86
3.62
1.4
1.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
24
104
2.31
3.58
1.2
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
19
74
2.57
3.54
1.6
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
65
402
1.62
3.43
1.7
1.5
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
16
58
2.76
3.41
1.1
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
130
934
1.40
3.37
2.7
1.9
nmol/l
1.0
0.8
2.35
114
786
(3034891) Synovial lining cells/100 cells in Synovial fluid
40
218
1.84
3.30
1.5
1.4
%
8.7
3.5
—
7
46
(3035285) Chloride [Moles/volume] in Venous blood
79
517
1.54
3.30
2.3
2.3
mmol/l
105.4
105.2
0.15
79
509
(3041354) Potassium [Moles/volume] in Venous blood
79
517
1.54
3.30
2.3
2.3
mmol/l
4.0
4.1
0.80
79
509
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
54
323
1.68
3.26
1.6
1.5
u/ml
21.1
20.0
0.08
14
68
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
26
122
2.14
3.25
1.1
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
77
505
1.53
3.20
1.7
1.4
e6/l
2084.4
2129.6
0.04
55
366
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
11
33
3.34
3.19
2.1
2.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
35
185
1.90
3.18
2.7
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
35
185
1.90
3.18
2.7
2.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
24
110
2.19
3.18
1.3
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
40
221
1.82
3.18
2.9
2.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
41
229
1.80
3.15
1.2
1.1
u/ml
7.0
23.9
—
6
21
(3029396) Erythrocyte agglutination [Presence] in Blood
15
55
2.73
3.15
2.7
3.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
189
1457
1.31
3.14
1.7
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
35
187
1.88
3.09
2.7
2.1
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
42
238
1.77
3.08
1.1
1.1
u/l
30.3
24.3
0.41
36
179
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
97
673
1.45
3.08
1.2
1.1
au/ml
13.6
10.6
—
10
41
(3045414) Leukocytes [Presence] in Urine
257
2065
1.26
3.08
2.0
1.9
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
70
454
1.55
3.07
1.7
1.4
e6/l
59153.0
84821.5
0.22
39
260
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
472
4034
1.19
3.06
1.4
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1361
12514
1.12
3.06
1.7
1.6
mmol/l
1.5
1.4
3.80
1121
10528
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
6
8
7.51
3.05
11.0
9.5
—
—
—
0
0
(3025315) Body weight
10
29
3.45
3.04
6.8
4.2
—
—
—
0
0
(1002224) Polysomnography panel
262
2114
1.25
3.03
1.0
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
13
45
2.89
3.02
1.2
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
51
308
1.66
3.00
2.8
2.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
22
100
2.20
2.99
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
172
1319
1.31
2.98
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
173
1332
1.31
2.92
1.2
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
26
128
2.04
2.90
4.0
3.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
26
128
2.04
2.90
4.0
3.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
25
122
2.05
2.86
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
446
3819
1.18
2.85
1.7
1.9
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
30
157
1.92
2.84
1.2
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
34
186
1.83
2.82
1.2
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
645
5690
1.15
2.81
4.5
4.4
%
31.6
32.2
0.57
495
3879
(3015183) Erythrocyte sedimentation rate
39
223
1.75
2.80
1.2
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
49
299
1.64
2.79
1.2
1.2
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
9
23
3.92
2.77
1.1
1.1
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
10
31
3.23
2.77
1.3
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
88
615
1.44
2.73
1.2
1.3
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
17
72
2.37
2.72
1.6
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
172
1338
1.29
2.72
1.2
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
104
750
1.39
2.71
1.2
1.2
u/l
28.9
46.2
1.16
93
653
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
38
218
1.75
2.71
1.4
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
38
218
1.75
2.71
1.4
1.6
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
31
167
1.86
2.71
1.3
1.6
pmol/l
20.8
15.3
0.67
26
143
(3020961) Endomysium IgA Ab [Titer] in Serum
259
2117
1.23
2.70
1.1
1.1
titre
265.0
213.3
—
8
57
(3009015) Lactate [Moles/volume] in Synovial fluid
14
54
2.60
2.70
1.5
1.2
mmol/l
4.8
5.7
—
6
26
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
19
85
2.24
2.70
1.2
1.2
%
81.8
74.3
—
10
26
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
23
113
2.04
2.61
1.3
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
418
3591
1.18
2.59
2.4
2.2
nmol/l
12.4
13.3
1.78
367
3208
(3019977) pH of Arterial blood
41
244
1.69
2.59
3.6
2.9
ph
7.4
7.4
0.48
11
85
(3011288) Drugs identified in Urine by Screen method
65
957
0.68
2.58
1.7
3.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
8
20
4.00
2.56
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
8
20
4.00
2.56
1.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
26
135
1.93
2.54
1.1
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
13
50
2.60
2.53
1.1
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
20
95
2.11
2.48
2.2
2.3
mmol/l
7.2
7.5
0.16
13
56
(3047189) Immunofixation for 24 hour Urine
37
217
1.71
2.47
1.7
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
48
302
1.59
2.46
1.2
1.2
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
8
21
3.81
2.46
1.5
1.6
%
1.9
2.0
—
8
21
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
23
116
1.99
2.45
6.8
7.3
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
12
45
2.67
2.45
1.3
1.3
mmol/l
237.1
157.7
1.10
12
40
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
75
521
1.45
2.44
1.4
1.3
—
34.0
—
0
6
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
51
2.55
2.44
1.2
1.0
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
35
203
1.73
2.44
1.1
1.1
u/ml
14.4
3.9
0.59
11
30
(3033923) Metanephrine [Moles/time] in 24 hour Urine
20
96
2.09
2.42
1.0
1.1
umol/24h
0.6
0.7
1.39
12
47
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
24
125
1.92
2.35
1.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
127
971
1.32
2.33
5.9
2.9
—
—
—
0
0
(44813793)
48
307
1.57
2.32
1.0
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
109
816
1.34
2.31
1.3
1.3
mmol/l
65.5
62.6
0.31
91
657
(3032743) Legionella sp IgG Ab [Presence] in Serum
9
28
3.22
2.30
1.4
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
94
688
1.37
2.30
1.6
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
395
3415
1.17
2.29
1.6
1.8
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
18
85
2.12
2.28
1.2
1.2
%
94.9
78.7
—
10
27
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
39
238
1.64
2.28
1.7
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
34
200
1.70
2.27
7.0
11.3
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
6
13
4.62
2.27
1.2
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
24
127
1.89
2.25
1.1
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
167
1332
1.26
2.22
1.9
1.7
mu/l
321.9
296.9
0.36
153
1213
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
9
29
3.11
2.22
1.0
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
9
29
3.11
2.22
1.4
1.0
—
—
—
0
0
(44806071)
14
60
2.34
2.21
1.1
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
41
256
1.61
2.20
1.1
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
22
114
1.93
2.20
1.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
27
150
1.80
2.19
1.1
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
82
592
1.39
2.19
1.2
1.3
nmol/l
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
409
4683
0.86
2.18
1.3
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
64
442
1.45
2.18
2.5
2.9
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
8
24
3.34
2.18
1.0
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
207
1697
1.23
2.17
1.6
1.6
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
75
535
1.41
2.15
1.1
1.1
u/ml
4.1
3.4
0.14
30
199
(3019768) Coxiella burnetii Ab [Presence] in Serum
9
30
3.00
2.14
1.3
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
64
444
1.45
2.14
1.6
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
260
2187
1.20
2.11
4.2
3.3
—
—
—
0
0
(3035880) pH of Pleural fluid
37
228
1.63
2.10
1.4
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
15
68
2.21
2.10
1.5
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
11
43
2.56
2.09
1.2
2.5
u/field
0.5
0.7
0.15
11
43
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
43
276
1.56
2.08
1.0
1.1
iu/ml
6.6
10.5
—
9
77
(3046861) Legionella sp Ag [Presence] in Urine
7
20
3.50
2.05
1.1
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
7
20
3.50
2.05
1.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
7
20
3.50
2.05
1.3
1.2
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
7
20
3.50
2.05
1.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
7
20
3.50
2.05
1.0
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1579
14890
1.08
2.00
4.5
4.6
ug/l
2.5
2.9
0.40
1419
13468
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
76
552
1.38
1.99
1.1
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
49
329
1.49
1.95
1.3
1.3
mmol/l
10.7
12.1
0.61
19
107
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
9
33
2.73
1.93
1.1
1.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
10
39
2.57
1.92
1.0
1.2
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
20
106
1.89
1.90
1.2
1.2
ug/l
14.1
384.9
—
9
51
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
18
92
1.96
1.89
1.3
1.3
mg/l
0.5
125.0
1.01
11
66
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
77
566
1.37
1.89
1.4
1.4
nmol/l
0.2
0.3
1.95
55
427
(3048879) Bone marrow aspiration report
24
136
1.77
1.86
2.5
1.9
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
143
1148
1.25
1.86
1.2
1.1
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
6
17
3.53
1.83
1.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
6
17
3.53
1.83
1.0
1.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
52
359
1.45
1.83
1.9
2.1
u/field
2.7
1.9
0.34
23
145
(1761482) Bacteria [#/volume] in Urine by Culture
133
1063
1.26
1.80
4.8
4.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
19
101
1.88
1.80
7.2
7.6
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
7
23
3.05
1.80
5.0
2.9
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
13
60
2.17
1.77
1.1
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
17
88
1.93
1.74
1.1
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
96
740
1.30
1.74
1.3
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
21
117
1.80
1.74
1.0
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
33
209
1.58
1.73
3.9
2.4
mmol/l
8.4
9.3
0.68
26
162
(40768806) Pleura Pathology biopsy report
63
456
1.39
1.73
1.7
1.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
50
347
1.44
1.72
1.9
2.1
umol/l
7.5
10.3
0.56
34
243
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
30
186
1.62
1.71
2.4
2.7
—
—
—
0
0
(4034850)
184
1533
1.21
1.71
11.3
9.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
11
48
2.29
1.70
1.0
1.1
umol/24h
1.8
1.7
0.06
11
48
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
26
156
1.67
1.68
1.4
1.4
%
69.8
62.7
0.42
20
129
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
16
293
0.54
1.67
13.8
18.3
nmol/l
1358.6
1448.7
0.19
16
286
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
23
134
1.72
1.65
1.2
1.1
%
76.1
91.0
—
10
73
(3017569) Oxygen content in Arterial blood
34
220
1.55
1.64
3.0
2.2
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
20
112
1.79
1.64
1.2
1.1
pmol/l
431.7
272.7
0.49
15
80
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
130
1050
1.24
1.64
2.0
2.1
u/l
3811.8
3823.3
0.00
43
389
(3000764) Benzodiazepines [Presence] in Urine
116
1442
0.80
1.60
1.8
2.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
10
43
2.33
1.60
1.4
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
132
1072
1.24
1.59
2.1
1.9
pmol/l
194.4
205.6
0.63
122
1017
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
104
824
1.27
1.56
1.1
1.1
u/ml
1.9
1.5
0.12
40
306
(3045683) HLA typing for celiac disease panel - Blood or Tissue
39
264
1.48
1.55
1.0
1.0
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
26
160
1.63
1.55
1.8
1.3
umol/l
2.7
4.0
1.21
21
149
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
21
122
1.72
1.54
1.5
1.6
ug/l
0.5
0.4
0.56
16
77
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
29
184
1.58
1.54
1.2
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
118
1452
0.81
1.51
1.8
2.1
—
—
—
0
0
(3042951) Complement C1q Ab [Units/volume] in Serum
6
21
2.86
1.50
1.0
1.1
—
26.9
—
0
6
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
21
123
1.71
1.50
1.2
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
118
1450
0.81
1.49
1.8
2.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
117
946
1.24
1.49
4.9
3.5
mg/l
23.5
26.3
0.45
75
576
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
254
2912
0.87
1.46
1.5
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
32
211
1.52
1.45
3.8
3.5
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
11
52
2.12
1.44
1.0
1.1
—
—
—
0
0
(4281824)
65
490
1.33
1.43
1.3
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
42
295
1.43
1.41
1.1
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
148
1236
1.20
1.39
1.1
1.1
u/ml
3.8
8.7
1.33
22
146
(3028717) Thiamine [Mass/volume] in Blood
10
46
2.18
1.39
1.1
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
70
536
1.31
1.39
1.5
1.7
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
29
2.42
1.39
1.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
14
74
1.89
1.38
1.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
14
74
1.89
1.38
1.4
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
84
660
1.28
1.38
1.1
1.1
u/ml
6.7
2.0
0.55
19
149
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
12
60
2.00
1.38
1.6
1.3
u/l
284.0
536.0
0.19
12
43
(3014133) Dog dander IgE Ab [Units/volume] in Serum
75
581
1.29
1.37
1.1
1.1
u/ml
5.3
2.7
0.48
35
209
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
16
89
1.80
1.37
1.4
1.2
—
—
—
0
0
(4146454)
65
494
1.32
1.36
2.6
2.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
215
2477
0.86
1.35
1.6
1.7
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
42
298
1.41
1.35
5.6
6.4
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
10
47
2.13
1.33
1.1
1.1
—
102.4
—
0
5
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
11
54
2.04
1.32
1.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
13
69
1.89
1.28
1.4
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
250
2198
1.14
1.27
1.3
1.4
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
21
130
1.62
1.26
1.2
1.3
%
71.1
91.7
—
9
71
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
399
4399
0.90
1.26
1.8
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
118
1419
0.83
1.25
1.8
2.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
16
92
1.74
1.24
2.0
2.6
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
9
45
2.00
1.23
2.7
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
111
1336
0.83
1.20
1.8
2.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
34
239
1.43
1.17
2.2
1.7
u/field
0.9
2.1
1.66
23
173
(3003888) Timothy IgE Ab [Units/volume] in Serum
90
730
1.24
1.17
1.1
1.1
u/ml
4.0
4.1
0.00
45
339
(3049717) Cytology report of Urine Cyto stain
189
1641
1.16
1.17
2.4
2.6
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
78
623
1.26
1.16
1.4
1.3
u/l
29.9
30.1
0.01
68
503
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
10
50
2.00
1.16
1.2
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
38
274
1.39
1.15
1.6
1.7
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
11
58
1.90
1.12
1.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
17
104
1.64
1.09
1.0
1.2
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
17
104
1.64
1.09
2.1
1.8
ug/l
1.9
1.9
0.00
12
57
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
56
434
1.29
1.08
1.0
1.1
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
15
89
1.69
1.07
2.6
3.1
ng/l
94.3
158.6
—
6
37
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
24
161
1.49
1.06
1.2
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
33
236
1.40
1.06
1.5
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1789
17269
1.05
1.05
3.0
2.8
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
20
129
1.55
1.05
1.6
1.3
mmol/l
3.5
3.3
0.11
20
115
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
617
5759
1.08
1.05
10.0
6.8
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
14
82
1.71
1.05
8.1
7.4
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
7
34
2.06
1.02
1.4
1.5
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
53
1.89
1.01
1.1
1.1
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
23
155
1.49
1.00
1.4
1.2
g/l
0.3
0.3
1.70
18
124
(3022621) pH of Urine by Test strip
319
2900
1.11
0.99
3.2
2.9
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
55
432
1.28
0.98
4.6
4.9
u/ml
110.3
70.7
0.25
22
123
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
30
215
1.40
0.97
1.0
1.0
%
89.9
95.7
0.49
24
170
(1001926) Buprenorphine [Presence] in Urine by Screen method
94
1121
0.84
0.97
1.9
2.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
10
54
1.85
0.96
1.1
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
16
100
1.60
0.96
2.2
2.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
17
108
1.58
0.96
1.2
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
79
649
1.22
0.96
1.1
1.1
u/ml
3.4
3.4
0.01
33
291
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
30
216
1.39
0.95
1.5
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
30
216
1.39
0.95
1.5
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
11
62
1.78
0.94
1.1
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
18
117
1.54
0.93
1.1
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
51
645
0.79
0.93
2.5
2.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
251
2263
1.11
0.92
1.0
1.0
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
6
28
2.14
0.91
1.2
1.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
6
28
2.14
0.91
1.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
11
63
1.75
0.90
1.2
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1243
11934
1.05
0.90
3.9
4.0
%
21.5
21.7
0.18
572
5493
(3027570) Oxalate [Moles/time] in 24 hour Urine
6
29
2.07
0.89
1.2
1.5
umol/24h
200.8
384.8
—
6
29
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
20
135
1.48
0.89
1.1
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
22
152
1.45
0.87
1.6
1.5
ug/l
9.1
8.8
0.16
22
152
(3022689) Creatine [Moles/volume] in Urine
21
144
1.46
0.87
1.2
1.5
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
11
64
1.72
0.86
1.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
12
72
1.67
0.85
2.3
1.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
56
451
1.24
0.84
4.2
3.0
mg/l
128.3
50.8
0.38
43
332
(3008401) Mugwort IgE Ab [Units/volume] in Serum
84
707
1.19
0.83
1.1
1.1
u/ml
2.7
1.0
0.34
34
276
(3020650) Glucose [Presence] in Urine
18
121
1.49
0.82
1.3
1.5
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
14
89
1.57
0.81
2.0
7.0
%
59.5
72.3
—
8
72
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
19
130
1.46
0.80
1.1
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
21
147
1.43
0.80
1.6
1.8
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.5
—
18.8
—
0
24
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
24
173
1.39
0.78
1.7
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
137
1552
0.88
0.77
1.8
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
88
750
1.18
0.77
1.1
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
24
174
1.38
0.76
1.1
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
6
34
1.77
0.76
2.2
1.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
39
305
1.28
0.76
1.2
1.2
mmol/l
29.4
35.2
1.23
32
266
(44816559) Phosphatidylethanol [Mass/volume] in Blood
104
901
1.16
0.75
1.2
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
210
1903
1.11
0.74
1.7
1.9
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
13
83
1.57
0.74
1.7
1.4
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
5
24
2.08
0.74
1.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
17
116
1.47
0.74
1.1
1.1
u/ml
14.5
5.2
—
6
13
(3020491) Glucose [Moles/volume] in Blood
43
344
1.25
0.71
1.3
1.8
mmol/l
7.5
6.7
0.87
33
224
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
7
40
1.75
0.71
1.1
1.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
31
238
1.30
0.70
2.5
2.0
ug/min
381.3
221.5
—
8
59
(3003740) Influenza virus B Ag [Presence] in Specimen
83
711
1.17
0.70
1.1
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
25
187
1.34
0.68
2.6
2.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
21
153
1.37
0.66
1.9
2.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
7
44
1.59
0.65
1.9
1.7
umol/l
48.1
42.2
—
7
44
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
82
712
1.15
0.61
1.1
1.1
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
8
51
1.57
0.60
1.9
1.4
%
68.2
76.7
—
8
45
(4198724)
13
186
0.70
0.59
1.8
2.7
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
10
64
1.56
0.58
1.1
1.5
%
9.6
9.1
—
5
34
(3014051) Protein [Presence] in Urine by Test strip
115
1026
1.12
0.58
2.5
2.2
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
30
237
1.27
0.58
1.0
1.0
u/ml
0.3
2.0
—
7
69
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
43
355
1.21
0.57
1.2
1.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
36
1.67
0.56
1.2
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
79
903
0.87
0.56
1.3
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
17
124
1.37
0.55
1.4
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
614
5878
1.05
0.54
1.6
1.8
%
1.4
1.5
0.15
532
5222
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
34
416
0.82
0.54
1.3
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
165
1510
1.10
0.53
1.6
1.8
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
21
160
1.31
0.53
1.8
2.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
4006
39688
1.03
0.52
27.4
17.7
g/l
332.3
332.6
0.91
3989
39413
(3013139) Helicobacter pylori Ag [Presence] in Stool
331
3118
1.07
0.52
1.2
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
26
205
1.27
0.52
2.3
2.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
9
63
1.43
0.52
1.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
6
40
1.50
0.51
1.0
1.2
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
6
40
1.50
0.51
1.3
1.2
u/l
6.5
18.7
—
6
40
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
20
258
0.77
0.50
1.2
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
14
101
1.39
0.49
2.0
2.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
29
234
1.24
0.49
1.3
1.3
nmol/l
149.3
139.4
0.49
29
234
(4094501)
152
1397
1.09
0.47
1.1
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
48
1.46
0.46
1.9
2.1
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
5
85
0.59
0.45
1.0
1.1
ug/l
79.5
77.5
—
5
69
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
50
1.40
0.45
1.3
1.3
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
20
156
1.28
0.45
1.9
2.0
e6/l
20514.1
16923.2
0.07
13
88
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
7
51
1.37
0.44
1.1
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
7
51
1.37
0.44
1.1
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
35
293
1.20
0.44
1.5
1.3
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
5
31
1.61
0.43
1.0
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
62
547
1.13
0.41
2.2
2.2
mg/l
20.3
21.9
0.10
16
144
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
15
0.00
0.41
0.0
1.2
—
2.2
—
0
15
(37019676) Renin [Units/volume] in Plasma --supine
0
15
0.00
0.41
0.0
1.1
—
11.1
—
0
8
(3006462) Nitrate [Presence] in Urine
26
213
1.22
0.40
3.0
3.5
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
5
34
1.47
0.40
6.8
4.4
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
13
98
1.33
0.37
1.4
1.4
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
5
37
1.35
0.37
1.2
2.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
15
116
1.29
0.37
1.1
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
9
70
1.29
0.36
1.0
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
9
70
1.29
0.36
1.0
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
9
70
1.29
0.36
1.0
1.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
54
480
1.13
0.34
1.0
1.1
u/ml
3.9
0.3
0.44
12
104
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
14
178
0.79
0.34
1.3
2.9
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
15
118
1.27
0.33
1.1
1.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
46
1.30
0.33
2.0
2.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
28
238
1.18
0.32
1.7
1.3
umol/l
40.9
24.3
1.40
28
226
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
45
400
1.13
0.30
1.4
1.4
pmol/l
53.4
143.1
0.65
18
128
(3035933) Granulocytes/100 leukocytes in Blood
15
120
1.25
0.30
1.6
1.6
—
—
—
0
0
(3014891) Appearance of Pleural fluid
7
55
1.27
0.30
2.1
1.5
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
25
213
1.17
0.29
1.4
2.2
umol/l
79.2
157.4
1.86
13
113
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
33
288
1.15
0.29
1.5
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
20
238
0.84
0.28
1.3
1.3
—
—
—
0
0
(4211845)
27
232
1.16
0.28
2.9
3.4
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
36
317
1.14
0.28
1.0
1.0
ng/l
770.0
740.7
0.15
31
215
(3026470) Cobalt [Mass/volume] in Blood
33
289
1.14
0.28
1.8
2.0
ug/l
4.6
3.0
0.27
27
254
(3009466) Valproate [Moles/volume] in Serum or Plasma
63
689
0.91
0.27
4.3
5.3
umol/l
342.9
364.7
0.57
55
603
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
36
318
1.13
0.27
1.0
1.0
ng/l
311.0
329.4
0.23
31
221
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
28
321
0.87
0.26
1.3
1.5
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
36
319
1.13
0.26
1.0
1.0
ng/l
45.3
45.0
0.02
29
217
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
140
1480
0.94
0.26
1.5
1.4
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
5
73
0.68
0.26
1.0
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
35
310
1.13
0.26
1.7
1.4
ug/l
2.3
3.6
0.63
29
245
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
33
293
1.13
0.24
1.7
1.7
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
84
0.71
0.24
2.0
2.2
umol/l
14.8
17.4
—
6
84
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
20
172
1.16
0.22
2.0
2.2
e6/l
768.9
686.0
0.13
14
124
(4212803)
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
11
0.00
0.21
0.0
1.3
—
132.5
—
0
11
(3002079) Sodium [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.1
—
126.8
—
0
10
(3037556) Urate [Mass/volume] in Serum or Plasma
16
135
1.19
0.21
1.3
1.4
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
8
103
0.78
0.21
1.0
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
882
8677
1.02
0.20
2.8
2.9
ug/l
0.8
0.7
0.15
546
5536
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
12
99
1.21
0.19
1.3
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
43
395
1.09
0.18
1.2
1.1
nmol/l
352.4
369.6
0.25
31
349
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
690
6781
1.02
0.18
1.5
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
97
1020
0.95
0.17
1.7
1.6
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
7
61
1.15
0.17
6.9
3.5
umol/l
27.1
41.3
—
7
50
(3014271) Vancomycin [Susceptibility]
24
214
1.12
0.17
3.2
2.8
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
61
574
1.06
0.15
1.3
1.2
mmol/l
7.5
7.5
0.02
47
436
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
17
193
0.88
0.15
1.6
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
66
623
1.06
0.15
1.6
1.4
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
10
83
1.21
0.15
1.1
2.6
ml/dl
16.7
14.8
—
10
77
(3020191) Ethanol [Moles/volume] in Serum or Plasma
36
389
0.92
0.14
1.1
1.5
promille
1.1
1.3
0.37
26
297
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
28
306
0.91
0.14
1.3
1.5
—
—
—
0
0
(4024509)
46
436
1.06
0.10
1.5
1.6
—
—
—
0
0
(44806420)
13
115
1.13
0.10
2.3
2.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
13
115
1.13
0.10
1.3
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
37
392
0.94
0.10
1.6
1.8
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
5
45
1.11
0.09
1.2
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
95
981
0.97
0.09
1.6
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
77
797
0.97
0.09
1.7
1.6
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
64
617
1.04
0.08
2.6
2.9
%
13.3
13.2
0.31
64
610
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
7
67
1.04
0.08
1.0
1.9
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
51
490
1.04
0.07
1.5
1.4
mosm/kgh2o
280.6
278.0
0.25
38
380
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
6
75
0.80
0.07
3.2
2.9
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
21
225
0.93
0.07
1.2
1.3
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
25
235
1.06
0.07
1.0
1.0
u/ml
0.5
0.6
—
6
52
(3044007) Cell count panel - Peritoneal fluid
13
142
0.92
0.06
2.2
2.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
45
461
0.98
0.03
1.5
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
55
560
0.98
0.02
1.4
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
19
198
0.96
0.02
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
146
1448
1.01
0.02
1.5
1.5
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
22
227
0.97
0.01
1.3
1.3
mmol/l
6.1
6.0
0.10
22
216
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
52
527
0.99
0.01
1.4
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
36
366
0.98
0.00
1.1
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
45
444
1.01
0.00
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
52
526
0.99
0.00
1.4
1.4
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
11
112
0.98
0.00
1.1
1.1
u/ml
0.2
1.5
—
6
56
(4133840)
13
125
1.04
0.00
1.1
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
32
322
0.99
0.00
1.3
1.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
44
442
1.00
0.00
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
52
525
0.99
0.00
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
52
525
0.99
0.00
1.4
1.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
21
207
1.01
0.00
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
46
457
1.01
0.00
1.4
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
105
1051
1.00
0.00
1.2
1.4
—
—
—
0
0
(3036005) Urine sediment comments by Light microscopy Narrative
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
99.1
—
0
5
(3029612) Listeria sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
9
92
0.98
0.00
1.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
7
77
0.91
0.00
3.3
6.6
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
1466.3
—
0
8
(36303858) Crystals [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
19
190
1.00
0.00
1.1
1.2
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
8
0.00
0.00
0.0
1.4
—
3210.0
—
0
8
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
59
1.02
0.00
4.0
11.2
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
0
6
0.00
0.00
0.0
2.0
—
5.2
—
0
6
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_SARCOIDOSIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_SARCOIDOSIS | 1.39 [1.25, 1.54] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.711 |
During the follow-up period (1.1.1998 — 31.12.2019), 1208 out of 9966 females with D3_SARCOIDOSIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_SARCOIDOSIS | 1.389 [1.25, 1.54] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.005 |
During the follow-up period (1.1.1998 — 31.12.2019), 1134 out of 8918 males with D3_SARCOIDOSIS died.
Mortality risk
Mortality risk for people of age
years, who have D3_SARCOIDOSIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.134% | 0.329% |
| 5 | 0.738% | 1.766% |
| 10 | 2.088% | 3.93% |
| 15 | 4.361% | 7.144% |
| 20 | 7.682% | 12.149% |
Relationships between endpoints
↥Index endpoint: D3_SARCOIDOSIS – Sarcoidosis
GWS hits: 21
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data